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Biophysical Investigation of Protein Interactions to Evaluate Protein Structure and 
Function 
Khiem Quoc Nguyen, PhD 
University of Connecticut, 2017 
 
 Proteins are essential macromolecules for the proper function and proliferation of 
life in tandem with carbohydrates, lipids, and nucleic acids. Even with our current 
understanding, novel proteins and protein-protein interactions are continuously being 
discovered, providing a better and clearer picture of cellular processes. In this 
dissertation, the work presented will focus on tackling how proteins interact with their 
ligands and what this tells us about the protein’s structure and function by utilizing 
biophysical techniques encompassing nuclear magnetic resonance spectroscopy and 
isothermal titration calorimetry. In chapter 2, we have studied the protein-protein 
interactions of cluster of differentiation 47 (CD47) and protein linking integrin associated 
protein to the cytoskeleton 2 (PLIC-2) and confirmed that the two do not associate in vitro 
under the conditions tested. It was anticipated that PLIC-2 could be a means for CD47 to 
modulate the cytoskeletal framework, but the lack of direct binding weakens that 
possibility. In chapter 3, the interaction between butyrophilin 3A1 (BTN3A1) and 
phosphoantigens (pAg) were explored, focusing specifically on the region between 
BTN3A1’s transmembrane helix and B30.2 domain, denoted juxtamembrane (JM) region. 
We have found that the JM region was able to weakly associate with pAg, where the 
important functionality is the negatively charged diphosphate moiety. This association is 
potentially vital for the activation of BTN3A1, where ligand association was found to be 
 
 
Khiem Quoc Nguyen – University of Connecticut, 2017 
 
 
able to induce a conformational change within the intracellular region of BTN3A1. In 
chapter 4, we explored the use of small molecules in order to probe the protein surface 
through NMR. By using select hydrophobic probes, it is possible to quantitate the overall 
surface hydrophobicity of a protein, which is important for understanding protein stability 
as solution properties, such as aggregation, have been linked to hydrophobic interactions. 
I have added an appendix chapter A1, which is related to my minor contribution to the 
structural refinement of skelemin and understanding its interaction with integrin. All in all, 
the work presented here focuses on protein interactions and how it can be related to its 
biological role and solution properties.     
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Chapter 1 – Introduction 
 
 
 Proteins as a whole have diverse roles and functions within the cell, such as a cell 
division, enzymatic, protein expression regulation, or even apoptosis. Understanding 
individual biological processes is fundamental for comprehending medical problems that 
may arise from protein mutations and/or deletions, but is an arduous task as the 
mechanical workings within the cell is a complex interplay of proteins, nucleic acids, lipids, 
carbohydrates, and small molecules. In this dissertation, I will investigate various proteins, 
such as CD47 or BTN3A1, and their binding partners in vitro to better understand their 
structure and function. There are numerous ways and instrumentation for a scientist to 
conduct research, but this introduction will provide a brief overview of the main techniques 
used in this dissertation. There are multiple references if a more in-depth explanation is 
required [1-5].  
 
1.1 – Isothermal Titration Calorimetry 
 Isothermal titration calorimetry (ITC) is a technique that can be utilized to 
characterize the thermodynamic parameters of interactions by directly measuring the 
heats of binding at constant temperature. These processes may be endothermic or 
exothermic, depending on whether or not they use or release heat, respectively. The heat 
detected is of particular importance as ITC is able to directly determine the change in 
enthalpy (ΔH) as shown in Figure 1.1. From the titration data, the equilibrium association 
constant (Ka) is determined from the slope at the inflection point.  
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Figure 1.1. Diagram of Important Parameters Determined by ITC. The binding curve 
presented here is a simulated curve using an independent binding model in which the 
concentrations were 800 µM and 100 µM for the titrant and protein, respectively. The Kd 
was set to 1 µM. The ΔH is determined by measuring the maximal difference in heat 
(between the dotted lines) and the slope (grey line) at the inflection point is related to the 
binding affinity, Ka. 
 
 
The determination of both the ΔH and Ka is very useful because they can be used to 
calculate the rest of the thermodynamic parameters through the equations: 
                                                 ∆𝐺 = −𝑅𝑇𝑙𝑛𝐾𝑎                                 (1) 
                                                 ∆𝐺 = ∆𝐻 − 𝑇∆𝑆                                (2) 
where ΔG is the change in Gibbs free energy, R is the gas constant, T is the temperature, 
and ΔS is the change in entropy. Equation 1 reflects the system at equilibrium, which 
allows for the calculation of ΔG at the experimental temperature. Afterwards, the ΔG can 
be plugged in equation 2 in order to determine the ΔS. As a result, we can be able to 
predict the thermodynamic parameters of the system of interest, where we can observe 
if it is enthalpically and/or entropically favorable. This is useful is gauging the strengths of 
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interactions, where entropic gains are generally from hydrophobic interactions whereas 
favorable enthalpies can be from hydrogen bonds and charge-charge interactions.  
 Though ITC is a powerful tool for evaluating the thermodynamic parameters, there 
are several practical considerations for performing ITC runs. The ITC measures the total 
heat from the system, which means that it detects the formation and/or breaking of 
hydrogen bonds from ligand-ligand and ligand-solvent interactions on top of the ligand-
protein interaction of interest. As such, this necessitates the evaluation of a titration 
control, where the ligand is titrated into the buffer in the absence of protein. This measures 
the heats of dilution, in which the ligand goes from a concentrated to a dilute state. The 
heat differences due to the ligand-ligand and ligand-solvent are subtracted from the actual 
experiment to more properly characterize the ligand-protein association. Another 
consideration to factor in is the c value, which is a relationship between the Ka and the 
concentration of the protein in the cell: 
                                                           𝑐 = 𝐾𝑎𝑛[𝑃]                             (3) 
where the n is the stoichiometry and [P] is the protein concentration in the cell. The 
acceptable range of the c value is generally between 10-100, which provides a 
reasonable binding curve as shown in Figure 1.1 (c value = 100). For the low volume 
NanoITC, this is appropriate for protein based interactions whose Kd values are usually 
in the low µM range as it translates to needing a protein concentration of approximately 
100 µM. Though the ITC is able to detect bindings within the nM to mM range, obtaining 
workable protein concentrations would be difficult as mM affinities require very high 
concentrations that may not be possible due to protein stability and aggregation. On the 
other hand, nM affinities require lower concentrations, which consequently means lower 
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sensitivity due to the reduced heats from binding. However, there are workarounds, such 
as competitive displacement experiments.   
 
1.2 – Nuclear Magnetic Resonance Spectroscopy 
 
1.2.1 – Overview of Key Principles 
 Nuclear magnetic resonance (NMR) spectroscopy is a sensitive and robust 
technique that relies on a property called the nuclear spin, I, that is dependent upon the 
composition of the nucleus (number of protons and neutrons). When subjected to an 
external magnetic field, there will be a (2I + 1)-fold degeneracy. If the nuclear spin is 0 as 
in the case for 12C, then there is only one energy level and excitation is not possible, 
rendering the nucleus to be undetectable by NMR. Since quadrupolar nuclei (I > 1/2) 
produce a much more complex spectrum due to multiple energy states, this overview will 
encompass the nuclei (1H, 13C, 15N) that possess a nuclear spin of 1/2. The relative energy 
difference between the two energy levels is directly proportional to the gyromagnetic ratio 
(an intrinsic property of the nucleus), γ, and the strength of the external magnetic field, 
Bo. As such, higher sensitivities can be achieved by observing nuclei with a larger 
gyromagnetic ratio like 1H as well as utilizing stronger external magnetic fields.  Since 
there is an energy difference between two states, it is possible to excite the nuclei as: 
                                                            ∆𝐸 = ℎ𝑣                                 (4) 
where h is planck’s constant and ν is the frequency.  
 Excitation is performed through the application of radio-frequency pulses for a 
specific duration, which leads to the rotation of the bulk magnetization from the z-axis. A 
complete transfer of the bulk magnetization to the xy-plane would correlate with a 90o 
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change, which is denoted as a 90o pulse. The bulk magnetization would then process 
about the xy-plane due to its angular momentum. The analogy commonly given is the 
spinning top, who spins stably if the vertical axis is aligned but has a precessional motion 
if the vertical axis is tilted.  
 The importance of the magnetization in the xy-plane is because a rotating 
magnetic field generates an electric current that is detectable by the instrument. The 
output is a digitized plot of the oscillation about the x or y plane called the free induction 
decay (FID). The signal decays over time due to natural relaxation processes that reduce 
the magnetization in the xy-plane to 0 and brings the bulk magnetization back to the z-
axis. The conversion from time to frequency domain is commonly done through the 
Fourier Transform in order to present the data as commonly seen for 1D, 2D, and 3D 
spectra.     
 
1.2.2 – Chemical shifts, Chemical Exchange, and Binding 
 Now, there is a slew of information that can be obtained from NMR. One piece of 
information comes from the chemical shift values. As stated before, the frequency for 
excitation depends on the external magnetic field. However, there is a local magnetic field 
as the nuclei also behave as bar magnets, which ultimately leads to minor, but detectable, 
differences in the larmor frequencies. The information of the local environments is useful 
for determination if the protein is folded and what kind of structure it has because the 
chemical shifts of amino acids in α-helix, β-sheet, or random coil have been extensively 
tabulated throughout the years. Furthermore, following chemical shifts and chemical shift  
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Figure 1.2. Diagram of Chemical 
Exchange and Motional Regimes. 
This depicts what we can expect to see 
in an NMR spectrum at the different 
motional regimes depending on 
exchange rate (kex) and chemical shift 
difference (Δδ), where fast is where the 
kex >> 2πΔδ, intermediate is kex ~ 2πΔδ, 
and slow is kex << 2πΔδ. The fast 
exchange regime shows an averaged 
peak that may show chemical shift 
changes when moving from 100% population A (black line) to 100% population B (grey 
line). The intermediate exchange also shows chemical shift changes, but is also 
accompanied by line broadening. Slow exchange does not show any sort of chemical 
shift changes, but rather shows the two distinct peaks and their relative populations.  
 
 
differences are standard practices for studying protein-protein and protein-ligand 
interactions. This is based on the equilibrium: 
                                                            𝐴←
→𝐵                                         (5) 
where the protein is able to interconvert between states A and B. This can apply for 
multiple conformations, but the common scenario would be for binding to ligands/proteins, 
where A is the apo state and B is the bound state. As the chemical shift is dependent 
upon the localized magnetic field, any association will mean that B has different chemical 
shifts from A located at the direct binding site or potentially indirect conformational 
changes. Now, what we actually observe is based on the rate of exchange, the chemical 
shift difference, and populations of A and B as shown in Figure 1.2. Nonetheless, 
chemical shift perturbations are a useful tool for detecting binding.  
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1.2.3 – Paramagnetic Relaxation Enhancement 
 Paramagnetic Relaxation Enhancement (PRE) experiments rely on the use of 
paramagnetic compounds, who possess an unpaired electron. The unpaired electron, like 
the nucleus, is able to generate local magnetic fields. However, the unpaired electron has 
a much larger magnetic moment than the nucleus, so that its presence greatly enhances 
the relaxation rate of nearby atoms up to ~10-25Å away. Thus, one can compare the 
differences in spectra of a protein in the presence and absence of a paramagnetic 
compound, where affected residues would have a reduced signal to noise ratio due to the 
rapid relaxation rate. This process can be utilized so that it is possible to detect solvent 
exposed residues, which could be subsequently protected upon complex formation. 
Alternatively, covalently attaching a paramagnetic compound to the protein can provide 
distance restraints by deciphering which residues are nearby in space.  
 
1.2.4 – Transverse Relaxation Time 
 Transverse Relaxation Time (T2) is the time it takes for the magnetization in the 
xy-plane to return to equilibrium. The main process that causes T2 relaxation is chemical 
shift anisotropy (CSA), which is the minor fluctuations in the individual localized magnetic 
environments. As mentioned previously, the bulk magnetization is excited and then 
detected through its precession within the xy-plane. However, this bulk magnetization is 
comprised on individual spins that are not all identical due to anisotropy, which causes 
the same atom (on different proteins) to precess at a different rate. This results in 
decoherence over time due to minor variability within the local field, where the bulk  
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Figure 1.3. Diagram of Decoherence. This schematic shows the bulk magnetization 
after excitation residing on the +y axis. After a certain period of time, the spins begin to 
precess in the xy-plane at various frequencies, leading to phase decoherence. As a result, 
the bulk magnetization, which is the sum of all the individual magnetization vectors, 
effectively gets reduced over time.   
 
 
magnetization is reduced, causing the reduction of detectable signal (Figure 1.3). This 
effect is related to the rotational correlation time, τc, which is the average time for the 
molecule to rotate one radian. It is important to note that τc is dependent upon the volume 
the molecule occupies, which implies that larger molecules like proteins will generally 
have slower correlation times and, thus, a shorter T2 in comparison to small molecules. 
 Another key factor that contributes to T2 relaxation is magnetic field 
inhomogeneities. Similarly to CSA, the precession of an atom in the xy-plane can be 
altered due to abnormalities in the Bo, such that the Bo felt by one atom is not the same 
at a different location in the NMR test tube. This is not a natural process by which 
relaxation occurs, but is rather due to experimental limitations in generating a uniform 
magnetic field through electrical currents flowing through a large superconducting coil and  
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Figure 1.4. Representation of Spin 
Echo and Usage. (A) shows the 
simplest spin echo pulse sequence 
(CPMG), where the proton is initially 
excited by a 90o x-pulse. After time, 
τ, a 180o y-pulse is applied to invert 
the magnetization in the x-axis. The 
spins are allowed to precess for 
another time, τ, for refocusing before 
acquisition. The spin echo, τ-180o-τ, 
can be repeated n times as needed. 
(B) is a visual representation of the 
refocusing as shown by the three 
colored arrows, who precess at 
different rates.  
 
 
smaller coils called shims. Fortunately, these experimental artifacts can be corrected for 
by applying a refocusing pulse.  
 A spin echo pulse sequence, where the simplest one is the Carr-Purcell-Meiboom-
Gill (CPMG) pulse sequence (Figure 1.4), applies an 180o y pulse after a period of time, 
τ, that inverts the magnetization on the x-axis. After the spins precess for an identical 
period of time, τ, the magnetization will all converge to a single point (Figure 1.4). As a 
result, the influence of experimental artifacts are negated through the refocusing pulse 
and the T2 relaxation seen is the true T2 value. It is important to note that the effects of 
CSA are not mitigated with this pulse sequence as this is a natural process that is 
fundamentally tied to random molecular motions whereas field inhomogeneities are not 
random and dependent upon the location within the magnet.    
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Chapter 2 – Uncovering if PLIC-2 is a 
Cytoskeletal Adaptor Protein of CD47 
 
Adapted from: Nguyen, K., Puthenveetil, R., and Vinogradova, O. Investigation of the 
adaptor protein PLIC-2 in multiple pathways, Biochem. Biophys. Rep., 2017, 9: 341-348. 
 
2.1 – Introduction 
2.1.1 – Overview of CD47 
 Cluster of differentiation 47 (CD47) is a ubiquitously expressed cell surface 
receptor [1] that consists of an extracellular IgV-like domain, five transmembrane helices, 
and a short unstructured cytoplasmic tail [2]. There are four different isoforms of CD47, 
differing only in their length of the cytoplasmic tail, where isoform 1 is the shortest and 
isoform 4 is the longest (Figure 2.1B). Each isoform is differentially expressed as isoform 
1 is found in keratinocytes, isoform 2 is ubiquitously expressed, isoform 3 is 
predominantly in the liver, and isoform 4 is found within the brain and peripheral nervous 
system [3, 4]. Though isoform 2 is the most abundantly expressed, it is unclear if there is 
functional relevance between the isoforms [3].   
 Nonetheless, CD47 was uncovered to be a significant player in the recognition of 
self, a mechanism by which our immune system precludes the removal of our own cells. 
CD47’s IgV-like domain is able to associate with signal regulatory protein-α’s IgV-like 
domain (SIRP-α), leading to the downstream activation of protein tyrosine phosphatases  
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Figure 2.1. Overview of PLIC-2 and CD47 Structure as well as the Potential Pathways. (A) 
Schematic showing the different domains and motifs of PLIC-2. It contains a well characterized N-
terminal UBL (ubiquitin like) domain and a C-terminal UBA (ubiquitin associated) domain. Interspersed 
between the two is the Body region which contains four Sti1 like domains and a repeat of twelve PXX 
motifs. (B) Schematic showing the overall structure of CD47. It consists of an N-terminal extracellular 
IgV domain, five trans-membrane helices and a C-terminal cytoplasmic tail. The tail is further 
differentially spliced from a single splice donor yielding the four isoforms of CD47. (C) A model 
representation showing the two pathways involving PLIC-2: (i) the proteasomal degradation pathway. 
This pathway is unrelated to the presence of CD47. Here the UBA domain of PLIC-2 binds to 
polyubiquitin chain bound to the substrate while the UBL domain interacts with the proteasome 
delivering the payload for degradation; (ii) the cytoskeletal regulation pathway. Central to this pathway 
is PLIC-2 which acts like an adaptor protein linking CD47 to Vimentin, an intermediate filament, hence 
by forging a link between the outer cell membrane and inner cell cytoskeleton. PLIC-2 has been 
proposed to interact with the cytoplasmic tail of CD47 [18]. We envision this interaction to occur in one 
of two ways: (ii-a) The UBA (or UBL) domain of PLIC-2 interacts with CD47, while the Body region 
interacts with vimentin filaments; (ii-b) the Body region of PLIC-2 interacts both with CD47 and 
Vimentin filaments. Meanwhile the UBL and UBA domains interact with each other. 
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 (SHP-1 and SHP-2) and inhibition of phagocytosis, especially in the case of mature red 
blood cells [5-7]. Furthermore, CD47 was found to be involved in regulation of 
angiogenesis and blood flow through its association with thrombospondin 1 (THBS1) and 
vascular endothelial growth factor receptors (VEGFR) [8]. Intriguingly, CD47 is also 
known by the name of integrin associated protein (IAP) due to experimental evidence 
where it co-precipitated with integrin αvβ3 [9] and was further expanded to include integrin 
αIIbβ3, α2β1, and α4β1 [10]. After being found to be identical to CD47, it is no longer referred 
to as IAP due to the fact that it is expressed and has a functional role in erythrocytes, who 
lack integrins [1].  
However, the molecular details of how CD47 is able to modulate cellular functions 
is currently unclear and has led to the interest in discovering novel proteins that may 
directly interact with CD47. There has not been much success, but there was a report by 
Wu and colleagues [11] that they had discovered two proteins that co-precipitated with 
the cytoplasmic tail (isoforms 2 and 4) of CD47. The proteins were found to increase 
CD47 related cell spreading and influenced the localization of vimentin filaments. This 
was a promising basis for how CD47 could modulate the cellular cytoskeleton, which is 
how the authors derived the name PLIC-1 and PLIC-2 (Proteins linking IAP with 
cytoskeleton).  
 
2.1.2 – Who are the PLIC Proteins? 
 Though they were discovered and named PLIC due to aforementioned evidence, 
PLICs are identical to a family of proteins called ubiquilins, which are human orthologs of 
the yeast Dsk2 family of proteins [12]. PLIC consists of a family of four homologous 
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proteins, PLIC-1 through 4. All contain a ubiquitin-like (UBL) amino-terminal domain; a 
body region, which is predominantly predicted to be disordered by DISOPRED [13] and 
Jpred [14] containing STI1 (stress inducible) heat-shock protein binding motifs [15, 16]; 
and a carboxyl-terminal ubiquitin-associated (UBA) domain (Figure 2.1A) [17]. PLIC-1 
and 2 are localized to the cytoplasm [18], PLIC-3 [19] is found in the testis and PLIC-4 is 
localized to the cell nucleus [20]. As mentioned previously, PLIC-1 and PLIC-2, also 
known as ubiquilin 1 and 2 respectively, had been shown to modulate the cytoskeleton 
through CD47. The direct interaction between CD47 and PLIC can be envisioned in 
Figure 2.1C, where it could be the individual UBL/UBA or the body region in direct 
association with CD47. The linkage to vimentin is most likely mediated through the body 
region.  
However, there have been conflicting data arising, where another study showed 
that double labeled immune-fluorescence of PLIC-1 and vimentin filaments did not show 
any co-localization [21] and that PLIC-1, but not PLIC-2, binds to Gβγ subunit of G 
proteins and interferes with its functionality. This was based on the observation that PLIC-
2 was predominantly present in the cytoplasm and never co-localized to the plasma 
membrane [22]. In addition, PLIC-1, but not PLIC-2, has been shown to inhibit Jurkat T-
cells migration by interacting with the βγ-subunit of the heterotrimeric G-protein [22]; and 
stabilize intracellular GABAA receptors to promote their accumulation within the plasma 
membrane [23]. Interestingly, PLIC-2, but not PLIC-1, down regulates endocytosis of the 
two unrelated GPCRs, V2 vasopressin receptor and beta-2 adrenergic receptor [24]. 
Though these studies highlight PLICs involvement in diverse cellular functions as a key 
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regulatory molecule, they seem to contradict its primary discovered role as a structural 
adaptor protein linking IAP/CD47 to cell cytoskeleton.  
 Furthermore, PLICs have been implicated to be involved in the ubiquitin mediated 
proteasomal degradation pathway. The primary machinery for this is the 26S proteasomal 
complex that is composed of a 19S regulator complex and 20S core complex, where 
polyubiquitinated proteins ultimately are degraded [25]. Evidence has been shown that 
the S5a subunit of the 19S component binds to the UBL domain of PLIC-2 [26]. Given 
that PLICs contain both a UBL and UBA domain and that other UBL-UBA shuttle proteins 
like Rad23 and Dsk2 have been characterized [27], it may be that PLIC serves as a shuttle 
for proteosomal degradation (Figure 2.1C) rather than a cytoskeletal adaptor protein. 
 It is a bit puzzling as to how two diverse modalities are built into a single structural 
design of these proteins. It seems pertinent to ascertain whether the UBL/UBA system is 
directly involved in linking cell surface receptors to intermediate filaments or whether it 
acts as a shuttle protein delivering its payload to the proteasomal complex for 
degradation. With the aim to reconcile these differences and understand which of the two 
pathways PLIC actually follows, we set to investigate the individual components involved 
in the interactions. We focused on uncovering if there was UBL/UBA self association or 
UBA/Ubiquitin binding, which are commonly seen for UBL-UBA shuttle factors, and if 
there was direct association with the cytoplasmic tail of CD47 isoform 4.  
 
2.2 – Materials and Methods 
Cloning of PLIC-2 and CD47 Constructs 
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PLIC-2/UBLN-2 (Accession number: Q9UHD9) UBL domain UBLN21-107 present 
in pET23a vector, was kindly provided by Dr. Walters (NCI. USA). PLIC-2 UBA domain 
UBLN2578-624 was sub-cloned into pET15b vector using BamHI and HindIII restriction 
sites. PLIC-2 Body region UBLN2108-580 was sub cloned into pET15b using NdeI and 
BamHI restriction sites. To ensure accurate measurement of the recombinant protein 
concentration, a single Tryptophan residue was inserted into the corresponding vectors, 
for both UBL and UBA, following the six Histidine tags. 
We used the longest isoform of CD47 (Isoform-4) as classified in the initial paper 
[18]. As per the Uniprot classification, this is annotated as Isoform-1. For this work, we 
will be following the classification from the original paper. Two constructs of CD47 
isoform-4 (Accession no.: Q08722-1) were designed for this study, (i)  CD47 290-323 
containing the residues comprising its cytoplasmic tail (CD47-CT) and (ii) CD47 269-323 
containing the residues comprising its last transmembrane helix along with its cytoplasmic 
tail (CD47-TMCT). The resulting amplicons were cloned into pET15b (for CT) (Novagen, 
USA) and pDB.His.MBP vector (for TMCT) (DNASU plasmid depository, USA) using the 
cutting sites NdeI and BamHI for the former and BamHI and HindIII for the latter. The 
pDB.His.MBP vector contains a Histidine-affinity tag and a MBP-fusion protein, separated 
from CD47’s sequence by a TEV protease cleavage site. Three additional glutamates 
were added before the N-terminal sequence to ensure proper accessibility of the cleavage 
site for proteolysis.  
 
Expression and Purification of the Recombinant Proteins 
Expression 
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All constructs were expressed in E. coli BL21 (DE3) (NEB, USA). Cell cultures 
were grown in either LB or M9 minimal media supplemented with 15N-labeled ammonium 
chloride as the sole nitrogen source at 37oC. When the cells reached an optical density 
(OD600) of ~0.4 to 0.6, the cultures were transferred to a shaker at room temperature (for 
most proteins) or a 17oC shaker (for PLIC-2 Body region), and left overnight after 
induction with 0.5-1mM IPTG.  
 
Purification  
UBA, UBL, Body, and CD47 constructs were purified using similar protocols with 
procedure variations outlined below. Harvested cells were resuspended and lysed using 
a French Press (Thermo Electron, USA). The supernatant was bound to Ni-NTA resin 
(Qiagen, USA) at 4oC for an hour, rinsed with ten column volumes of the wash buffer 
before elution. The eluate was further subjected to size exclusion chromatography (SEC) 
on a Superdex 75 (GE Healthcare, USA) for UBL and UBA domains, or Superdex 200 
(GE Healthcare, USA) for CD47-TMCT.  In addition to Ni-NTA purification the Body region 
was further purified using anion exchange chromatography  on Resource Q (GE 
Healthcare, USA), with a 0-30% gradient of Buffer A (20mM Tris, pH 8.0) and Buffer B 
(20mM Tris, 1M NaCl, pH 8.0). The Body containing fractions were further subjected to 
SEC on a Superdex 75 column.  
CD47-CT expressed in inclusion bodies was purified under denaturing condition. 
Briefly, cells were resuspended in 6M GuHCl in Tris buffer saline (TBS) buffer pH 8.0. 
Following lysis the supernatant was separated through centrifugation at 10,000 rpm and 
mixed with Ni-NTA resin at room temperature for 2 hours. The resin was rinsed first with 
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four column volumes of 8M urea in TBS with 10mM imidazole. Elution was carried out in 
the 8M Urea buffer containing 400mM imidazole. The eluate was loaded onto a Proto 300 
C4 column (Higgins Analytical Inc., USA) and purified using a 10-40% gradient of (Buffer 
A: 90% H2O, 10% Acetonitrile, 0.1% TFA and Buffer B is 10% H2O, 90% Acetonitrile, 
0.1% TFA). CD47-CT containing fractions were pooled and lyophilized (MillRock Tech., 
USA). 
 
Nuclear Magnetic Resonance Spectroscopy 
15N-labeled proteins were overexpressed in M9 medium supplemented with 
15NH4Cl as the sole nitrogen source. 15N-NMR experiments were performed with a 
concentration of 75-150 µM on a Varian 600 MHz spectrometer equipped with an inverse 
triple-resonance cold probe at 25oC. All spectra were processed with NMR Pipe [28] and 
analyzed in CcpNmr software suite [29] made available through NMRBox.  
For CD47-TMCT nanodiscs experiments, 15N-CD47-TMCT was titrated with 
unlabeled UBL at a ratio of 1:5 and Body region at 1:3. 15N-UBL was titrated with 
unlabeled CD47-TMCT at a ratio of 1:5, whereas 15N-UBA was titrated with unlabeled 
CD47-TMCT at a ratio of 2:5. For CD47-CT experiments, 15N-UBL was titrated with 
unlabeled CD47-CT at a ratio of 1:10 and 15N-UBA was titrated with unlabeled CD47-CT 
at a ratio of 1:10. For PLIC-2 self-association experiments, 15N-UBA was titrated with 
unlabeled UBL at ratios of 1:1, 1:3, 1:5, and 1:10. For UBA and ubiquitin experiments, 
15N-UBA was titrated with unlabeled ubiquitin at ratios of 3:1, 2:1, 1:1, 1:2, 1:3, 1:5, 1:10. 
Kd values were determined form the chemical shift perturbations calculated using the 
following equation [30]: 
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                                            ∆𝛿 = √0.5(𝛿𝐻
2 + (𝛼𝛿𝑁
2 ))                                    (1) 
where the scaling factor, α, was set to 0.15. The plot of the chemical shift perturbation vs. 
molar ratio was fitted to the equation below to define the Kd [31]: 
                   ∆𝛿𝑜𝑏𝑠 = 0.5∆𝛿𝑚𝑎𝑥 (1 + 𝑥 +
𝐾𝑑
[𝑃]0
− √(1 + 𝑥 +
𝐾𝑑
[𝑃]0
)
2
− 4𝑥 )               (2) 
where [P]0 is the concentration of 15N-UBA PLIC-2 and x is the molar ratio of UBL or 
ubiquitin to UBA.  
 
Isothermal Titration Calorimetry 
All ITC experiments were performed using a low volume Nano-ITC (TA 
instruments, USA). The titrations were done at 25oC with 200 RPM mixing, 300 s injection 
intervals, and 2.5 µL injections. The buffer used was 40 mM NaPO4, 20mM NaCl, 0.5 mM 
EDTA, pH 7.0. The protein concentrations for the syringe and sample cell were as follows: 
0.95 mM UBL PLIC-2 and 0.14 mM CD47-CT, 0.39 mM UBA PLIC-2 and 0.05 mM CD47-
CT, 0.49 mM CD47-CT and 0.05 mM Body PLIC-2, and 0.49 mM CD47-CT and 0.04 mM 
Body PLIC-2. For nanodiscs, 0.35 mM UBL PLIC-2 and 0.07 mM CD47-TMCT; 0.32 mM 
UBA PLIC-2 and 0.07 mM CD47-TMCT. Data analysis was done with the NanoAnalyze 
Software (TA Instruments, USA) suite using “independent” model algorithm. 
 
Molecular Modeling 
PLIC-2 UBA was modeled through Phyre 2 [32] web server using PLIC-1 UBA 
domain as a template which shares 98% identity.  Models of the protein complexes (PLIC-
2 UBA-UBL and PLIC-2 UBA-Ubiquitin) were calculated through the HADDOCK (High 
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Ambiguity Driven protein-protein DOCKing) [33] webserver using the chemical shift 
perturbation data obtained from NMR HSQC titration experiments. The structures of the 
participating proteins were acquired from the RCSB database (PLIC-2 UBL: 1J8C, 
Ubiquitin: 2JY6, PLIC-2 UBA: 2JY5).  
 
2.3 – Results and Discussion 
2.3.1 – Determination of the UBA/UBL Self Association 
We first tried to ascertain the involvement of PLIC-2 in the proteasomal 
degradation pathway. We initiated this by determining whether the two terminal UBA and 
UBL domains of PLIC-2 interact with each other (Figure 2.1C (i)). 15N-HSQC based 
chemical shifts perturbation (CSP) experiments were employed, where 15N labeled PLIC-
2 UBA was titrated against unlabeled PLIC-2 UBL. Peaks representing maximum 
observed perturbations (marked with asterisk on Figure 2.2), were used to calculate the 
Kd values using the equations summarized in the methods section. The average Kd value 
obtained was 175±25 µM, which is comparable to the previously reported Kd value of 
80±15 µM measured for Dsk2, a yeast homolog of PLIC proteins, [34]. It is known that for 
UBL-UBA proteins involved in proteasomal degradation, UBL interacts with the 
proteasome while UBA binds to polyubiquitinated substrates [17].  
        From reliable partial assignments transferred from PLIC-1’s UBA domain [35], we 
identified most of the PLIC-2 UBA residues which undergo perturbations in the presence 
of PLIC-2 UBL. These residues either belong to the loop region connecting helices α1 
and α2 (M592-F594) or are located within helix α3 (I615-E616 and L619) of which I615 showed 
minimal shifts. These positions match well with the corresponding Dsk2 residues M342- 
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Figure 2.2. PLIC-2’s UBA Domain is Able to Self-Associate with its UBL domain. 
15N-HSQC titration experiments of PLIC-2 15N-UBA domain in the presence of PLIC-2 
UBL domain at a UBA to UBL molar ratio of 1:1, 1:3, 1:5, and 1:10. Partial amino acid 
assignments were achieved by aligning the 15N-HSQC to that of PLIC-1 UBA domain [35]. 
The inset shows a molecular model displaying the interaction of UBA (grey) and UBL 
(red) as determined by HADDOCK. Two residues M and G showing maximum 
perturbation are shown as slices on the right.  
 
 
F344 from the same loop region and L365-D366, L369 from the α3 helix. Defining the binding 
site are residues M342/592, which fits snugly in the hydrophobic cavity of UBL, and L365/I615 
and L369/619, which reinforce the hydrophobic core. It is likely that the flexibility required for 
the two terminals domains to interact with each other is satisfied by having a Body region 
that is largely disordered.  
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Figure 2.3. PLIC-2’s UBA Domain Exhibits Large Chemical Shift Perturbations upon 
Titration with Ubiquitin. 15N-HSQC titration experiments of PLIC-2 15N-UBA domain in 
the presence of ubiquitin (Ub) at a UBA to Ub molar ratios of 3:1, 2:1, 1:1, 1:2, and 1:3. 
Ratios 1:5 and 1:10 are not shown as the spectra reached a saturation at 1:3. A molecular 
model, determined by HADDOCK, of UBA PLIC-2 (grey) and ubiquitin (red) as inset in 
the spectra. On the right, specific peaks are shown separately to better capture the 
chemical shift perturbations. Two residues M and G displaying intermediate exchange 
are shown as slices on the right. 
 
 
2.3.2 – Uncovering if UBA and Ubiquitin Interacts 
Thus, we next examined the ability of PLIC-2 to bind ubiquitinated substrates 
through the interaction of PLIC-2 UBA domain with Ubiquitin (Ub). Our titration 
experiments demonstrate a stronger binding affinity of UBA for Ub, as exemplified by the 
pronounced CSPs in 15N-HSQC spectra (Figure 2.3). The Kd value for this interaction was 
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determined to be 8.1±1.5 µM by averaging fits from peaks with pronounced perturbations, 
which is similar to PLIC-1’s affinity for ubiquitin (Kd ~20 µM) [35]. CSP data was further 
utilized to generate a model of the binding interface between UBA-UBL and UBA-Ub 
using HADDOCK, which is presented as inset within the spectra in Figures 2.2 and 2.3. 
Intermolecular interaction between UBA and Ub is stronger than with UBL and their 
binding interfaces involves the same core residues in addition to other exclusive to the 
UBA-Ub interactions reflective of stronger binding. CSP data obtained from our titration 
experiments of 15N UBA with Ub highlights residues M592-F594 from the (helix α1/ α2) loop 
region and A614-L619 belonging to helix α3 that are involved in this interaction. Majority of 
the perturbations belong to the fast exchange regime as only chemical shift perturbations 
were observed. However, residues M592-G593 displayed both chemical shift perturbations 
and peak broadening indicative of intermediate exchange. This is part of the canonical, 
M-G-F containing binding site conserved throughout UBA domains of PLIC/Dsk2 and 
hHR23/Rad23 proteins. In addition, I615-E616 and L619 from α3 showed significant 
perturbations, as has been observed for I580-E581 and L584 form PLIC-1 where they form 
close contacts with the hydrophobic patches of Ub [36]. Interestingly, T607, the last residue 
from the helix α2 showed shifts which can be attributed to its close proximity to A614 on α3 
which exhibited strong CSP a feature also observed with PLIC-1. All together, we can 
conclude that the UBA-UBL and UBA-Ub interactions in PLIC-2 share the same binding 
interface, which is exemplified in the HADDOCK models presented as insets in Figure 2.2 
and 2.3. 
Now, in order for PLIC proteins to participate in the proteasomal degradation 
pathway, two events need to occur. First, the UBL domain needs to interact with the 
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proteasome and, second, the UBA domain needs to interact with ubiquitin. The former 
has already been established for PLIC-2, where the UBL domain has been shown to 
complex with hRpn13 (Adrm1) [37], which is a subunit of the 19S regulatory particle of 
the 26S proteasome. In this chapter, we determined that PLIC-2 UBA domain is able to 
associate with ubiquitin. From our Kd estimation, the PLIC-2 UBA-Ub binds stronger than 
UBA-UBL. Given that UBA and UBL domains associate with each other, a stronger affinity 
of the PLIC-2 UBA domain for ubiquitin implicates the disengagement of the UBA-UBL 
domains in the event of PLIC binding to the polyubiquitinated substrate en route to the 
proteasome. This strongly suggests the role of PLIC-2 as a shuttle protein transferring its 
cargo to the proteasome for degradation. 
 
2.3.3 – Evaluating Binding of CD47 to the UBL and UBA Domains 
Next, we moved on to investigate the second half of our model, testing PLIC-2 as 
an adaptor protein linking the cell membrane to the cytoskeleton through the cytoplasmic 
tail of CD47 (Figure 2.1Cii). This was achieved by determining interactions occurring 
between CD47 and (a) the two terminal UBA/UBL domains of PLIC-2 or (b) the Body 
region of PLIC-2. Two constructs of CD47 were utilized, one containing the cytoplasmic 
tail region (CT) and the other comprising of the last transmembrane helix in addition to 
the cytoplasmic tail (TMCT). This helped investigate interaction at both the aqueous and 
membrane/water interface. Since CD47 is a mammalian receptor protein, we assessed 
the possibility of posttranslational modifications (PTM) using several PTM databases from 
Uniprot. We found that although there are ten positions that potentially undergo PTM, the 
last is located at residue 206. As our longest CD47 construct (TMCT) starts from residue  
Chapter 2 – Uncovering if PLIC-2 is a Cytoskeletal Adaptor Protein of CD47 
 
25 
 
 
 
Figure 2.4. Absence of Any Observable Interaction Between CD47-CT and PLIC-2 
UBA/UBL Domains. (A) 15N-HSQC of PLIC-2 15N-UBL alone (black) and in the presence 
of CD47-CT at a UBL to CD47 ratio of 1:10 in red. (B) 15N-HSQC of PLIC-2 15N-UBA 
alone (black) and in the presence of CD47-CT at a UBA to CD47 ratio of 1:10 in red. (C) 
(Top) ITC thermogram of UBL titrated into buffer (black) and into CD47-CT (red). (Bottom) 
Integrated heats of the titration after correction for the heat of dilution.  (D) (Top) ITC 
thermogram of UBA titrated into buffer (black) and into CD47-CT (red). (Bottom) 
Integrated heats of the titration after correction for the heat of dilution.  
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number 269, no PTMs affect the outcome of our study, validating the biological 
significance of our in-vitro analysis. 
In order to ascertain whether CD47 interacts with the UBL and/or UBA domains of 
PLIC-2, we performed 15N-HSQC titration experiments with 15N-UBL or 15N-UBA. Figures 
2.4A and 2.4B present the spectra of the UBL and UBA domains, respectively. Both 
remained unperturbed by the addition of the cytoplasmic tail of CD47 (CD47-CT) with no 
CSPs or peak broadenings. To reinforce our results, we performed Isothermal Titration 
Calorimetric (ITC) experiments where CD47-CT was titrated against the UBL (Figure 
2.4C) or UBA domains (Figure 2.4D). The acquired thermograms reflect the heats of 
dilution rather than specific enthalpy driven interactions consistent with the lack of binding. 
The other pertinent question to this interaction is the proximity of the tail region to 
the membrane surface, as in its native receptor state. To identify any interactions at this 
interface, we incorporated the CD47-TMCT, containing the last transmembrane helix, into 
small D7 nanodiscs [38]. Nanodiscs offer a soluble lipid bilayer system allowing the study 
of interactions at the membrane/water interface. We have previously successfully 
employed NMR for the study of the  TMCT regions of Integrin β3 in nanodiscs [39]. Work 
done by Dr. Puthenveetil showed that nanodiscs formation was successful by TEM and 
that there was no binding by NMR or ITC with the CD47-TMCT construct, indicating that 
the addition of a membrane mimetic does not produce any observable binding between 
CD47 and the UBL or UBA domains of PLIC-2. 
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Figure 2.5. PLIC-2 Body Region Does not Bind to CD47-TMCT.  15N-HSQC of labeled-
CD47 TMCT. (A) 15N-CD47 TMCT alone (black) and in the presence of PLIC-2 Body 
region at a CD47 to Body ratio of 1:3 in red. The amide peak with a slight intensity drop 
in the presence of Body is marked by the asterisk. Inset: Negatively stained TEM 
micrograph showing the formation of nanodiscs containing the incorporated 15N labeled 
protein (B) 15N-CD47 TMCT alone (black) and in the presence of PLIC-2 UBL domain at 
a CD47 to UBL ratio of 1:5 in red. 
 
2.3.4 – Investigation of the CD47 and PLIC-2 Body Region 
Since no interactions were observed between the PLIC-2 UBA/UBL domains and 
CD47, we focused our attention on the PLIC-2 Body region. This is a 51.6 kDa intrinsically 
disordered protein that would provide a 15N-HSQC spectrum with a multitude of 
overlapping peaks corresponding to random coil frequencies making it difficult to observe 
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any CSP or peak broadenings leading to inconclusive and ambiguous data. Therefore, 
we tried to analyze this interaction from the side of CD47 by titrating 15N-CD47-TMCT 
with unlabeled Body region. We also performed the same experiment with the unlabeled 
UBL domain serving as a control; and additionally confirming the above obtained results 
for the 15N-UBL and unlabeled CD47-TMCT experiment. Figure 5 shows the spectra of 
15N-CD47-TMCT alone (black) titrated against unlabeled proteins, Body (Figure 2.5A) and 
UBL (Figure 2.5B) shown in red. Both titration resulted in no pronounced changes in 
resonance frequencies or peak intensities of CD47. There was however, a slight intensity 
drop observed for the amide located at 8.20/116.56 ppm in the presence of the Body 
region (marked with the asterisk in Figure 2.5A); but a minor intensity drop for a single 
peak does not substantiate a binding interaction between two proteins.  
The absence of binding was further confirmed through ITC measurements using 
the CD47-CT construct (Figure 2.6). ITC measurements were performed to confirm the 
lack of binding from the NMR data between CD47 and PLIC-2 Body region.  The initial 
titration of the Body region with CD47-CT showed some heat differences that could be 
interpreted as a binding curve. However, after careful analysis of the full data set, we 
concluded that it wasn’t the case.  Our rationale is based on the following arguments. 
First, the overall heat differences are low, so the data is close to the measurement limits  
and is at the noise level making each single titration unreliable. To overcome this 
limitation, we performed two titrations with a constant concentration of CD47-CT as a 
titrant into two different concentrations of the PLIC-2 Body protein present inside the 
measurement cell. If the observed calorimetric isotherms and the corresponding titration 
curves reflect a real binding event, we expect the lower concentration of PLIC-2 to  
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Figure 2.6. ITC Confirms the Lack of Interaction Between PLIC-2 Body Region and 
CD47. ITC thermograms of CD47-CT titrated into buffer (black) or into PLIC-2 Body 
region (red) at two different concentrations of PLIC-2 protein. The normalized fit shows 
the heats for both 50µM and 40µM PLIC-2 Body region. 
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saturate earlier owing to a lower requirement for a titrant concentration. In fact, we got 
opposite results, which indicates the artificial nature of observed curves as the point of 
saturation for 50µM of Body came sooner than the one for the 40µM titration. Lastly, if we 
forcefully fit the thermogram to obtain a binding constants, the data would place a Kd 
value into the low 100 nM range, which is a relatively strong binding affinity and should 
be easily detectable by NMR spectral analysis (as we demonstrated earlier for even 
weaker PLIC-2 inter domain interactions which were the µM range).  Taken together, we 
believe that the observed shifts in heat values were likely produced due to proteins 
aggregation during titration, manifested by acquired samples cloudiness visible upon 
experiments completion.  
 
2.3.5 – Does PLIC-2 Directly Associate with CD47? 
 The evidence presented here clearly indicates that PLIC-2 does not associate with 
CD47 in vitro. Though it seems to contradict the report from Wu and colleagues [11], the 
inference that the two may not be directly associated is not inconceivable when we factor 
in the following reasons. It is important to keep in mind that the work done here is 
performed on isolated domains of PLIC-2 (UBA, UBL, and Body region), where the full 
length protein may adopt an overall fold necessary for interacting. For instance, the 
UBA/UBL self association may be fairly weak as presented here (Kd = 175±25 µM), but 
there is evidence of PLIC-2 forming dimers/trimers [40] possibly through the Body region 
[41] , which may promote intermolecular UBA/UBL association. 
Furthermore, it is probable that CD47 and PLIC-2 are part of a larger 
macromolecular assembly that may also contain, for example, integrin heterodimers [42]. 
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The sole in vitro data available for PLIC’s interaction is from a pull down assay using 
recombinant GST-fused PLIC probed against CD47 from human placenta and analyzed 
through immunoblots [11]. This doesn’t rule out the presence of other proteins that could 
have been part of the pull down result and hence doesn’t exclude the possibility that other 
protein(s) might be involved in the complex formation. Silver staining of the pull down 
eluate followed by subsequent LC-MS might help identify these components. Since this 
experiment was not performed in the original study, the direct interaction of CD47 to PLIC 
remains a conjecture.  
On the other hand, there is a possibility that PLIC-2’s role may not be a cytoskeletal 
adaptor protein at all, but rather serves an entirely different function altogether. Several 
studies have shown the involvement of PLICs in alternative cellular processes, such as 
proteasomal degradation [27, 43], GPCR endocytosis [24], clathrin mediated endocytosis 
through Eps15 and and Epsin (1 and 2) [24], and evidence in this chapter indicating that 
it is able to bind to ubiquitin. To complete the picture, recent evidence has arisen 
illustrating the functional role of the Body region, which had been elusive thus far as there 
was no established binding partner despite being predicted to contain six STI1 heat shock 
binding motifs. A recent study by Hjerpe and colleagues has implicated the Body region 
to associate with heat shock protein 70 (HSP70) whom is bound to an aggregated client 
protein. The entire complex (PLIC-2/HSP70/Target protein) is then transferred to the 
proteasomal complex for degradation. Specific mutations linked to amyotrophic lateral 
sclerosis located within the Body region were shown to abolish PLIC-2/HSP70 complex 
formation [40], highlighting the significance of recycling protein aggregates. The data 
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suggests that the Body region is responsible for payload transfer and potentially substrate 
recognition, further consolidating PLIC-2’s role as a proteasomal shuttle factor.   
 
2.4 – Conclusion 
Even though we employed high sensitivity/ high-resolution biophysical techniques, 
we did not observe direct interactions between the cytoplasmic tail of CD47 and any of 
the individual domains of PLIC-2. Both ITC and NMR results consistently refute the notion 
of a binary complex. Though it is possible that the conditions for our in vitro analysis may 
not have been ideal, the evidence of UBA/UBL self association and UBA/Ubiquitin 
complex formation coincides with the current literature showing that PLIC-2 belongs to 
the proteasomal degradation pathway. This raises questions against its involvement as a 
protein linking the membrane to the cytoskeleton and leaves one to ponder whether the 
name Ubiquilins should be preferred over PLIC while referring to these adaptor proteins. 
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Chapter 3 – Investigating the Role of the 
Juxtamembrane Region of BTN3A1 in Ligand 
Induced Activation 
Adapted from: Nguyen, K., Li, J., Puthenveetil, R., Lin, X., Poe, M., Hsiao, C.C., 
Vinogradova, O., and Wiemer, A. The butyrophilin 3A1 intracellular domain undergoes a 
conformational change involving the juxtamembrane region, FASEB J., just accepted. 
 
3.1 – Introduction 
3.1.1 – Butyrophilins, Phosphoantigens, and the Immune Response 
 The butyrophilins (BTN) are type I receptor glycoproteins with further classification 
as BTN1 (A1), BTN2 (A1, A2, A3), and BTN3 (A1, A2, A3) subfamilies [1]. They possess 
diverse functionalities as BTN1 is involved in the milk secretion during lactation whereas 
BTN2 and BTN3 were found to be able to activate/inhibit the immune system [1, 2]. In 
particularly, BTN3A1 has been the focus of attention due to recent studies have 
identifying it to be essential for the activation of Vγ9Vδ2 T cells [3-5]. These T cells, upon 
activation, respond by quickly lysing the target cells by generating pro-inflammatory 
cytokines [6, 7]. Given the clinical potential to use this mechanism as a means for the 
removal of cancerous entities, it is imperative to understand the activation mechanism of 
BTN3A1 and how it eventually translates to the activation of Vγ9Vδ2 T cells. 
 BTN3A1 is a ~54kDa protein, after removal of the signal peptide, that contains two 
extracellular Ig domains (IgC and IgV), a single transmembrane helix, an intracellular 
B30.2 domain, and a stretch of 68 amino acids, denoted as the juxtamembrane (JM) 
region, between the transmembrane helix and B30.2 domain (Figure 3.1). BTN3A1 is  
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Figure 3.1. Representation of BTN3A1 and Diphosphates. In (A), a simplistic diagram 
of BTN3A1 is shown to better visualize its domains and positioning of domains, where 
IgV and IgC domains reside in the extracellular region, a single transmembrane helix, and 
the intracellular JM region and B30.2 domain. Since the focus is on the intracellular 
region, the structure of B30.2 bound to cHDMAPP (PDB ID: 47NU) while showing the 
nearby positively charged residues. The JM region is not structurally characterized, but 
models (calculated through I-TASSER [24] (model 1) or MODELLER (model 2) [23]) show 
that a potential for a highly helical features. (B) shows the ligands used within this chapter 
as well as cHDMAPP, which was used in the crystal structure [14]. It is important to note 
that the nomenclature can be inconsistent at times in the literature as HMBPP can also 
be referred to as HDMAPP, which more clearly shows its relation to cHDMAPP and 
DMAPP.    
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activated upon association with phosphoantigens (pAg), who are small molecules that 
possess a diphosphate moiety. The B30.2 domain possesses a strong affinity for (E)-4-
hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP), where its Kd is ~2 µM [8]. 
Interestingly, HMBPP is a natural product that is known to be synthesized in bacteria, but 
not in humans, through the non-mevalonate pathway as a precursor for the formation of 
isopentyl disphosphate (IPP) [9], who has a ~71000 fold weaker EC50 than HMBPP for 
the expansion of Vγ9Vδ2 T cells [8]. This highlights the potential for targeting BTN3A1 as 
its activity depends on exogenous compounds and that not all disphosphate containing 
compounds readily activate BTN3A1, sparking the interest for synthesizing HMBPP-
derviatives and prodrugs [8, 10, 11] or drugs that stimulate pAg accumulation [12, 13].   
 
3.1.2 – The Binding Pocket and BTN3A1 Activation 
 Given that the drug target and ligand is known, Sandstrom and colleagues 
provided a crystal structure of the B30.2 domain in its apo (PDB ID:4N7I) and bound (PDB 
ID: 4N7U) state [14]. The bound state was crystallized through the use of a HMBPP-
derivative, hydroxy-methyl-butyl-pyrophosphonate (cHDMAPP), that was chemically 
crosslinked through the use of glyceraldehyde. The B30.2 domain contains two β-sheets 
within its core with a positively charged shallow binding pocket for cHDMAPP (Figure 3.1), 
where mutations that reversed the charge (H351R) abrogates pAg association. Though 
it appears to be clear that the binding pocket resides on the B30.2 domain of BTN3A1, a 
comparison of the apo and bound form illustrates the lack of a conformational change 
upon ligand association. This is a bit troubling as it does not provide additional insight in 
the possible activation mechanism of BTN3A1. 
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 BTN3A1 activity could be related to its association with protein partners. For 
instance, periplakin has been found to be relevant in the activation of Vγ9Vδ2 T cells [15], 
which is predicted to be due to the direct association to the JM region, as well as RhoB, 
whose association with BTN3A1 is weakened if HMBPP is present [16]. However, there 
is little detail of the binding interfaces and how exactly HMBPP could influence protein-
protein interactions.  
To examine this conundrum, a previous report by Hsiao and colleagues had 
investigated if there was a difference between the BFI (construct contains the JM and 
B30.2 domain) and the B30.2 domain upon interacting with HMBPP [8]. Though the ITC 
results reported indicated that the Kd and ΔH values were similar between the two 
constructs, the NMR spectra had shown remarkable differences in chemical shifts for the 
BFI/HMBPP titration that were not observed for the B30.2/HMBPP titration. Given that the 
difference between the two constructs is the presence of the JM region, it can be 
postulated that the JM region is involved in some way with ligand association. This is an 
important clue to understanding how BTN3A1 may be activated as the large chemical 
shift differences could be indicative of a conformational change that encompasses the JM 
region. Therefore, the work presented here will investigate the role of the JM region in 
HMBPP-induced activation. 
 
3.2 - Materials and Methods 
Protein Purification 
Following sequencing, all the recombinant clones were transformed into E.coli BL-
21 (DE3) cells and grown on an agar plate with antibiotics specific to the vector. A single 
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colony was transferred to LB broth and grown overnight at 37 °C to be transferred to LB 
or M9 minimal media. For M9 minimal media, 15NH4Cl and/or 13C-glucose were added as 
the sole sources of nitrogen and carbon. Cells were induced with 1 mM isopropyl β-D-1-
thiogalactopyranoside once they reached an optical density of 0.5 and harvested after 4 
hours. 
The JM region was purified under denaturing conditions from recombinant 
expression within inclusion bodies. A base buffer containing 8 M urea, 100 mM Tris, and 
200 mM NaCl at pH 7.4 was used. Cells were resuspended in lysis buffer (base buffer + 
5 mM imidazole) and lysed by three passages through French Press (Thermo Electron, 
USA). The lysate was centrifuged at 12,000 rpm. Supernatant containing the denatured 
protein was mixed with Ni-NTA resin (Qiagen, USA) at room temperature for 2 hours. The 
resin was washed with 10 mM imidazole and eluted with 300 mM imidazole in base buffer. 
The eluate was loaded onto a Proto 300 C4 column (Higgins Analytical Inc., USA) and 
purified in a 10-40% gradient formed by buffer A (90% H2O, 10% acetonitrile, 0.1% 
trifluoroacetic acid) and buffer B (90% acetonitrile, 10% H2O, 0.1% trifluoroacetic acid). 
Protein fractions were collected and lyophilized for later use. SDS-PAGE analysis was 
performed to analyze the purity of the purified protein. 
 
Nuclear Magnetic Resonance Spectroscopy 
All NMR experiments were performed on a Varian INOVA 600 MHz spectrometer 
(Agilent, USA) at 25oC. Protein-protein interaction studies were carried out through 1H-
15N HSQC experiments collected using 2048*128 increments. The interaction between 
JM and HMBPP, DMAPP, GDP, and sodium diphosphate was accessed in buffer 
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containing 100 mM MES, 50 mM NaCl, 5 mM BME, and 8% D2O at pH 6.5. HMBPP, 
DMAPP, GDP, and sodium diphosphate was added in a molar excess of 10 times the 
concentration of the JM region protein. 
Spectra for backbone assignments (HNCACB, HNCA, HN(CO)CA, CBCA(CO)NH) 
were collected using 1024*32*16 increments in the direct, carbon, and nitrogen 
dimensions, respectively. HNCO experiments were executed with lower increments in the 
carbon dimension (ni = 16). Experiments were performed in the presence of 5 mM 
dodecylphosphocholine (Avanti Polar, USA). Peak peaking was performed using CcpNmr 
software suite [17] and chemical shifts of assigned peaks were used to predict protein 
secondary structure through the TALOS+ webserver [18]. 
 
3.3 – Results and Discussion 
3.3.1 – HMBPP Induced Conformational Change  
 Previously, published work [8] provided evidence that the JM region was affected 
in some way after the addition of HMBPP when you compare the bound B30.2 and BFI 
15N-HSQC spectra. This was a novel discovery due to the fact that it currently is unknown 
as to how HMBPP binding leads to the activation of BTN3A1. Given that HMBPP affects 
the JM region as well, it was postulated that ligand binding induces a conformational 
change within the intracellular region of BTN3A1.  
 To confirm that this does occur, SAXS (done by Dr. Puthenveetil) was used to 
visualize the surface envelope of BFI in the presence and absence of HMBPP as shown 
in Figure 3.2. Both BFI and BFI/HMBPP exhibit globular shapes, indicating that the JM 
region is likely to be unstructured rather than a rigid α-helix. When we compare the  
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Figure 3.2. The BTN3A1 Intracellular Domain is a Globular Structure that is 
Compacted upon HMBPP Binding. (A) Schematic representation of the rearrangement 
of the BFI region (JM+B30.2 domain) in the presence of HMBPP. (B) Scattering curve for 
BFI in the presence (blue) or absence (green) of HMBPP and overlay of the normalized 
pair-distance distribution curves P(r) of the scattering curves. (C) Surface representation 
of the average ab initio model for BFI and BFI+HMBPP rendered through SITUS [25], 
where the JM is colored separately in red. The dotted lines represent the missing residues 
between the JM and B30.2 in our model.  
 
 
differences between the two surface envelopes, we see that the addition of HMBPP 
causes a reduction in the radius of gyration (Rg) by ~ 2Å and Dmax by ~8 Å. This reduction 
can be characterized as BFI compacting upon ligand association, which provides 
evidence that a conformational change does occur. Since SAXS only provides a low 
resolution envelope, it is difficult to define the molecular details of the conformational 
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change. However, we hypothesized that HMBPP binding to B30.2 leads to a reorientation 
of the JM/B30.2 as visualized in Figure 3.2A and 3.2C.   
 This hypothesis was also based on the crystal structure of the apo and bound 
form of B30.2 obtained by Sandstrom and colleagues [14]. The calculated backbone 
RMSDs between the apo and complexed B30.2 (4N7I vs. 4N7U) was 0.094Å by matching 
amide nitrogens using Chimera [19], which is negligible. As a result, ligand binding 
appears to have minimal or no affect on the overall structure of the B30.2 domain. Thus, 
we predict that the conformational change is related to the relative orientation of the B30.2 
and JM region. However, one caveat is that the crystal structure was crosslinked with the 
ligand, implicating that it may not properly depict the true bound state of B30.2. It is then 
not possible to completely rule out that the B30.2 can undergo its own conformational 
changes in combination with the JM.   
 
3.3.2 – Juxtamembrane and Diphosphates 
 To properly evaluate the molecular details of this conformational change, we opted 
to utilize an NMR approach. However, evaluation of the JM region within the BFI construct 
was not feasible due to serious spectral overlap. To circumvent these difficulties, we have 
chosen here to investigate the JM region directly and therefore we cloned the isolated 
BTN3A1 JM region consisting of 68 amino acid residues at position 272-339. Though we 
planned on studying the interaction between the isolated JM region and B30.2 domain 
constructs, the pH requirements for solubility of the constructs appeared to be 
incompatible. This led to a high propensity of the two domains to precipitate upon mixing 
under any buffer conditions we tested. 
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Therefore, we opted to test whether the JM region could directly associate with 
HMBPP as an avenue for facilitating the conformational change. We have found that the 
majority of JM amides in 15N-HSQC spectrum are sharp and lay within the range of 
random coil chemical shifts values (8.5 -7.5 ppm), reflecting predominantly unstructured 
ensemble of conformers in a fast exchange. Several peaks are broader though, indicating 
an exchange getting to the intermediate range. As the binding is expected to be weak 
due to the absence of the B30.2 domain, HMBPP was titrated in at a 10 fold excess. 
Comparison of the JM region alone and the JM region with HMBPP shows that there are 
spectral differences and that the differences are not drastic, implicating that HMBPP 
associates weakly to the JM region (Figure 3.3A). The major effects are characterized by 
differences in line shape, such as peak sharpening, rather than chemical shift 
perturbations (Figure 3.4), suggesting a very dynamic nature of the ensemble of 
conformers in exchange. One affected amide, marked by the asterisk in Figure 3.3A and 
located within the region where serine/ threonine residues are usually found, indicates 
that HMBPP binding promotes one particular conformation for this amino acid from 
several potential conformations in intermediate exchange. 
Since HMBPP was able to bind to the JM region, we sought to determine the 
appropriate functional group responsible for interacting. For this, we tested the effect of 
DMAPP, a molecule whose chemical structure is identical to HMBPP barring the absence 
of the allylic alcohol (Figure 3.1B). We found that DMAPP interacts with the JM region 
with a very similar pattern of chemical shift perturbations (Figure 3.3B) as HMBPP, 
indicating that the allylic alcohol is nonessential for the interaction. Interestingly, the JM 
region also weakly associated with GDP and sodium diphosphate (Figure 3.3C/D), two  
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Figure 3.3. The JM Region Interacts with Various Diphosphates. (A) HSQC of JM 
alone and with HMBPP at a 1:10 ratio. There are minor differences as marked by the 
asterisks, signifying that HMBPP weakly associates with JM. The overall effect of binding 
is nearly identical for (B) JM:DMAPP, which implies that the hydroxyl of HMBPP is 
nonessential for binding. 15N-HSQC titrations of JM with GDP (C) or sodium diphosphate 
(D) at a 1:10 ratio show similar differences as marked by the asterisks, which shows that 
GDP and sodium diphosphate are able to interact with the JM region similarly to HMBPP. 
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Figure 3.4. Quantification of Peak Lineshape Changes. (A) 15N-HSQC that shows all 
resonances for JM WT in the absence of DPC. No assignments were done, but peak 
numbers are shown to better visualize the peaks evaluated in (B) and (C). In (B) and (C), 
a compound graph shows normalized linewidth in relation with the peak intensity of the 
JM alone in the absence of DPC. Peaks with minimal or no overlap were selected and 
were ordered based on their peak intensity, where peaks 1, 2, and 6 correspond to 
S303/T304 and peaks 5 and 7 correspond with S296/T297. Quantification was performed 
by analyzing spectra generated without the use of apodization functions. The line width 
of the 1H and 15N were averaged (𝜈𝑎𝑣𝑒 = √
𝜈𝐻
2 +𝜈𝑁
2
2
) first and then normalized by setting the 
averaged linewidth of JM only to 100 for individual peaks. (B) shows the linewidth 
difference upon addition of HMBPP and the standard deviation is shown (n=2), whereas 
(C) is with DMAPP, GDP, or diphosphate.  
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diphosphates that do not activate BTN3A1. Similarly, the effects on peak shape were 
consistent between all ligands tested (Figure 3.4). Given the common functional groups 
of these ligands is the negatively charged diphosphate, this suggests that the diphosphate 
moiety participates in the interaction with the JM region while the allylic alcohol, which is 
necessary for high potency interactions, likely binds to the B30.2 binding pocket rather 
than the JM region.  
 However, the interactions we observed by NMR are weak with minimal spectral 
changes. To further confirm that the diphosphate is associating with the JM region, Dr. 
Poe performed competitive binding assays by ITC (Table 3.1) using the BFI and B30.2 
constructs as the binding affinity of HMBPP to the isolated JM region is too weak for 
competitive binding. The addition of 100x molar excess of sodium diphosphate to BFI was 
able to reduce the ΔH from -53.7 kJ/mol to -32.9 kJ/mol while becoming more entropically 
favorable as TΔS increased from -21.6 kJ/mol to -1.1 kJ/mol, suggesting that diphosphate 
alone is able to competitively bind to BFI. In comparison, the addition of 100x molar 
excess of sodium diphosphate to B30.2 showed a less pronounced change in the ΔH 
(from -53.7 kJ/mol to -38.4 kJ/mol) and ΔS values (from -23.0 kJ/mol to -7.7 kJ/mol). 
Though modest, the effect of the diphosphate is lessened in the absence of the JM region, 
which indirectly substantiates that the JM is involved in the interaction with the 
diphosphate. 
Table 3.1. Summary of the Thermodynamic Data Derived from ITC Measurements 
Under Different Conditions. 
Sample ΔH (kJ/mol) TΔS (kJ/mol) Kd (µM) n 
BFI -53.7 -21.6 2.36 0.845 
BFI + Diphosphate -32.9 -1.1 2.61 0.860 
B30.2 -53.7 -23.0 4.27 0.994 
B30.2 + Diphosphate -38.4 -7.7 4.10 1.070 
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Thus, the model that we envisioned was that HMBPP could potentially interact with 
the JM region as well. This notion is also consistent with the B30.2/C-HMBPP crystal 
structure because a closer look at the electron density of the bound ligand only shows a 
well-defined tetrahedral moiety suitable for fitting the β-phosphate functional group. This 
suggests that the other portion of HMBPP was flexible as it was not visualized by x-ray 
crystallography [14]. This could be due to non-optimal cross-linked conformation of the 
apo B30.2 used for crystallization as discussed above, which was not able to promote 
additional contacts, such as with H381 or other nearby residues [20], including the ones 
from JM region. Our data suggests that the JM region may coordinate with the second 
exposed phosphate given that DMAPP, which lacks the allylic alcohol, GDP and even 
simple diphosphate still show the same weak association with the JM region. 
 
3.3.3 – NMR of the JM Region in the Presence of DPC Micelles 
 Since the JM was determined to interact with diphosphates and this could 
potentially key for the activation of BTN3A1, we needed to further characterize the 
molecular details of this interaction. Given that we have been performing NMR 
experiments, the logical step would be to perform 3D experiments and assign the 
backbone amide resonances. However, the JM region is sparingly soluble and has a 
tendency to aggregate, leading to inadequate quality necessary for 3D experiments. To 
improve protein solubility and stability, we performed backbone assignments of the JM 
region in the presence of dodecylphosphocholine (DPC) micelles (Figure 3.5). The quality 
of the spectrum was greatly improved as witnessed by the increased signal to noise ratio. 
Unfortunately, the degeneracy of the JM region’s primary sequence due to the large  
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Figure 3.5. DPC Enhances Stability and Solubility to Allow for Partial Assignments. 
(A) 15N-HSQC that shows all resonances for JM WT in the absence of DPC. (B) 15N-
HSQC of JM Wild Type in the presence of 5mM dodecylphosphocholine. Partial 
assignments of the protein were done and assignments are shown. For T297 and T304, 
conclusive assignments were not possible, but two peaks are labeled with a high 
probability of being a threonine. The secondary structure was predicted from the chemical 
shifts of the assigned residues using TALOS+ and is shown in (C). 
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Figure 3.6. Scheme for Sequential Assignments by Matching Resonances. 
Illustration of the scheme behind backbone assignments, where sequential amino acids 
can be determined by the alignment of the Cα and Cβ shifts. The experiments provide 
shifts for the residue itself (i) and the previous residue (i-1). The above shows multiple 
strips of different 15N chemical shift from HNCACB and HNCA experiments, where 
alignments are shown by dotted lines. 
Chapter 3 – Investigating the Role of the Juxtamembrane Region of BTN3A1 in Ligand Induced Activation 
 
51 
 
number of sequentially repeated amino acids (QQQEEKK, RKKKR, etc.) combined with 
the low solubility and conformational heterogeneity made it difficult to fully complete the 
resonance assignments. An example of the sequential assignments is shown in Figure 
3.6, where the alignment of the Cα and Cβ chemical shifts determined the string of amino 
acids.  
From the partial assignments (as marked in Figure 3.5B), we were still able to 
predict the secondary structure of the JM region, which shows that the C-terminus is 
highly helical and the N-terminus begins as a random coil (Figure 3.5C). Though the 
central region was not adequately assigned, the disparity of the proton shifts falls within 
a narrow region around ~8.2 ppm, indicating that it is likely that it is predominantly random 
coil. This is substantiated by our SAXS data that shows the probability of a dimeric coiled-
coil structure is minimal, at least in the absence of the transmembrane linker. Also, the 
repeated HxxHCxC motif or a tryptophan/leucine zipper, which is typical of dimeric coiled 
coils, is not found in the JM sequence. This is strikingly different than most prediction 
servers, where it predicts that the JM is highly helical and forms a coiled coil structure 
[21-24]. However, it is also possible that the JM region could become helical upon ligand 
binding, especially due to the conformational change relative to the B30.2 domain. 
However, this could not be experimentally validated due to the buffer incompatibilities of 
the isolated B30.2 and JM region.  
With the partial backbone assignments, we hoped that it would cover residues that 
were perturbed upon HMBPP association. We have tested whether the JM region 
interacts with HMBPP in the presence of detergent mimicking membrane-water interface 
and found that zwitterionic DPC competes with negatively charged diphosphate ligands  
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Figure 3.7. HMBPP is Able to Interact with the JM at Low Concentrations of DPC. 
15N-HSQC of the JM region in the presence of DPC at a ratio of 1:40 (A) and 1:120 (B). 
HMBPP was titrated in at a 1:10 ratio. Minor line broadening is observed in (A) as marked 
by the asterisk while no significant differences is seen in (B) when the DPC ratio is much 
higher.  
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for JM binding in a concentration dependent manner. At a low JM:DPC ratio (1:40), 
several peaks broaden upon addition of HMBPP, indicative of binding, whereas a higher 
ratio (1:120) showed no significant changes due to the saturation of one peptide molecule 
per micelle (Figure 3.7). Based on the low JM:DPC ratio, we focused on identifying the 
residues involved with interacting with HMBPP. Despite the fact that these amino acids 
could not be conclusively assigned, unique chemical shifts indicated that at least one 
threonine residue was involved. The JM construct contained only three threonine residues 
(at positions 279, 297 and 304). Since T279 was assigned, the partial residue 
assignments narrowed down the HMBPP binding to the JM region to occur at one of these 
two positions. This also coincides well with the JM data in the absence of DPC, which 
shows perturbation of peaks within the spectral region that is generally 
serines/theronines. Thus, we focused our efforts on mutation of the three non-conserved 
amino acid residues found in these two ST sequences and generated a ST296AA mutation 
and a T304A mutation. 
 
3.3.4 – Investigation if JM Mutants Associate with HMBPP 
To further confirm our conclusions from NMR data hampered by partial 
assignments, we investigated JM point mutants to uncover if those two threonines had a 
functional role. As shown in Figure 3.8, both mutations clearly altered the NMR spectrum 
in the expected region as alanine mutations would greatly affect the chemical shift of the 
residue mutated and sequential amino acids. By looking for peaks that are greatly shifted, 
we identified peaks correlating with S296, T297, S303, and T304. Interestingly, the point 
mutations lead to pronounced chemical shift changes beyond sequentially adjacent  
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Figure 3.8. Specific Mutations Perturb the JM Threonine Spectra and Inhibit HMBPP 
Interaction. 15N-HSQC comparison of JM and (A) its ST296AA mutant or (B) its T304A 
mutant. Based on the chemical shift changes, peaks corresponding to the mutated 
serine/threonine residues were identified, where solid lines represent confident 
assignment and dashed lines are slightly ambiguous. The mutations affect multiple peaks, 
suggesting that these point mutations affect the local structure. HMBPP was titrated into 
the mutants at a 10:1 HMBPP:JM ratio, but no interaction was seen for (C) ST296AA or 
(D) T304A. 
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residues, suggesting that there may be some local structure within the JM region as it 
affects residues through space rather than through bond.    
We assessed whether HMBPP was able to interact with the JM mutants and found 
that there was essentially no difference between the 15N-HSQC of each mutant in the 
presence and absence of HMBPP. Thus, we concluded that there is no association of 
HMBPP to the JM mutants, meaning that both threonine residues are important for 
HMBPP binding to the JM region.  
 
3.3.5 – Correlation of NMR data with In Vivo Experiments 
Though the evidence so far shows that JM likely interacts with the diphosphate 
moiety, the interaction is fairly weak and it requires further investigation to properly 
confirm its functional significance. For this, we looked at the effect of the threonine 
mutants in vivo on the activity of BTN3A1. Cellular assays using K562 cells and interferon-
γ quantification, performed by Jin Li, had shown that the mutants were able to reduce the 
EC50 of HMBPP from 0.056 µM (WT BTN3A1) to 3.1 µM and 3.8 µM for ST296AA and 
T304A mutants, respectively. The effect was statistically significant and was validated 
against control experiments (BTN3A1 surface expression levels, BTN3A1 knockout 
negative control, BTN3A1 knockout + WT transfected control). The activity of the mutants 
fell between the activity levels of the WT BTN3A1 and BTN3A1 KO, providing evidence 
that the threonines do serve a functional role in vivo. 
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3.3.6 – A Binding Model 
Based on the SAXS, NMR, and ITC, it is clear that a conformational change occurs 
and that the JM is involved. The relevance of this interaction is further elevated based on 
the cellular assays, which showed that the mutants ST296AA and T304A showed a 
statistically significant reduction in BTN3A1 activity, validating that the JM region is 
essential for Vγ9Vδ2 T activation. Thus, the binding model that we hypothesized based 
on these findings (presented in Figure 3.2A) shows that the binding of HMBPP to B30.2 
is likely to cause a conformational change in the orientation of the B30.2 and the JM 
region. Once the B30.2 and JM region come in close proximity, the exposed phosphate 
group could potentially interact with the JM region to form a B30.2/HMBPP/JM clamp. 
Our NMR data shows that one threonine (T304) is more affected, indicating that this is 
likely close to the binding pocket. The role of ST296/7, on the other hand, could lie in its 
ability to stabilize some local fold and/or its involvement in forming a binding interface with 
B30.2. 
 Nonetheless, the two threonine mutations resulted in the reduced activity of 
BTN3A1, emphasizing that the induced conformational change was a key step towards 
the activation of Vγ9Vδ2 T cells. The results point towards two possibilities that could 
ensue. First, the conformational change within the intracellular domain could transverse 
to the extracellular domain, leading to its recognition by T cells. This is consistent with the 
conclusions from a recent report where FRET approach was used to show that 
bisphosphonate treatment alters the extracellular conformation of BTN3A1 [16]. Second, 
the conformational change could lead to the recruitment and/or dissociation of 
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intracellular binding partners, for example, RhoB [16] or periplakin [15], eventually 
facilitating T cell activation. 
 
3.4 – Conclusion 
 To conclude, our studies indicate the importance of the BTN3A1 JM region for the 
interaction with isoprenoid diphosphates and how its activated state is induced by ligand 
binding. Evidence points to the involvement of threonine residues T297 and T304, which 
was shown to be relevant in both in vitro and in vivo studies. Though further work will 
need to be done to completely understand the molecular details and interface of this 
interaction, it will be interesting to find out how the structural changes can impact the 
functions of BTN3A1, especially in regards to the full length BTN3A1. Though we present 
here the analysis of conformational changes within the intracellular domain, it remains to 
be seen how the effects propagate across membranes and to the extracellular surface.  
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Chapter 4 – NMR as a Semi-Quantitative Tool for 
the Evaluation of Surface Hydrophobicity 
 
4.1 – Introduction 
4.1.1 – Proteins in the Industry 
 Though proteins are essential components naturally produced and regulated 
within our body, there has been increasing interesting in the development of biologics for 
medicinal purposes. When we deal with these proteins in the industrial setting, there is a 
large focus on the overall stability of the protein, considering that they would be subjected 
to a number of hostile environments during processing. One of the major setbacks of 
protein formulations is the stability, which includes the propensity of the protein to unfold 
and/or aggregate [1]. This scenario has been observed with antibodies [2], which is 
unfortunate because of the high monetary cost and safety concerns associated with 
antibodies [3, 4].  
The stability of a protein is a difficult parameter to assess and predict, but one key 
component is its hydrophobicity. Hydrophobicity has been accepted to be vital for the 
folding of proteins, where the hydrophobic effect leads to the internalization of nonpolar 
residues [5, 6], as well as protein-protein interactions between hydrophobic patches on 
the surface of the protein [7-9]. However, surface hydrophobicity is also responsible for 
nonspecific protein interactions, leading to protein aggregation, protein self-association, 
and surface adherence [1, 10-12]. Though hydrophobic interactions are not the sole 
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driving force for protein interactions, understanding this phenomenon would be beneficial 
in early determination if a protein would be likely to be stable.    
  
4.1.2 – Methods for Quantification of Protein Hydrophobicity 
In order to properly understand the role of hydrophobicity in the overall behavior of 
the protein, it becomes essential to quantify its hydrophobic character. This can be 
classified to be as the net hydrophobicity, which accounts for all nonpolar side chains 
present, or the surface hydrophobicity, which only deals with the solvent exposed 
nonpolar side chains [13, 14]. Though they are both important, surface hydrophobic is a 
major contributor to physical instabilities, such as protein self-association, aggregation, 
and adsorption to interfaces [1, 15, 16]. Therefore, focusing specifically on quantification 
of the surface hydrophobicity would be ideal for which different experimental techniques 
have been used. 
Hydrophobic Interaction Chromatography (HIC) is a purification method that has 
relatively mild solution conditions compared to other chromatographic techniques such 
as Reverse Phase Chromatography [17-19]. In HIC, the proteins bind to a stationary 
phase composed of a nonpolar hydrocarbon chain. The mobile phase consists of a high 
concentration salt, such as ammonium sulfate, in order to promote protein/column 
association. As the salt concentration is gradually decreased, the proteins will begin to 
elute off the column in the order of their hydrophobicity, where the least hydrophobic 
protein would elute first. As a result, it is possible to compare the surface hydrophobicity 
of proteins. 
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Unfortunately, there are caveats associated with HIC that should be considered. 
The strength of the protein’s association with the column is highly dependent on the 
experimental conditions, such as temperature, salt, and ionic strength of the mobile 
phase, which could considerably change the retention times of the proteins [19-23]. This 
makes it particularly difficult to compare hydrophobicities of proteins unless the 
experimental conditions are identical. The protein is also subjected to a fairly high ionic 
strength of salt buffer, which could screen electrostatic interactions, meaning that it may 
be an untrue representation of the hydrophobic characteristics of the protein as a whole. 
It is important to keep in mind that HIC solution conditions are not equivalent to 
formulation and storage buffers.  
 Another method is the use of extrinsic fluorescence probes, such as ANS, Bis 
ANS, and Prodan. This method works because these probes have differing properties in 
an aqueous or hydrophobic environment. In the aqueous environment, the probes have 
a low quantum yield. When the probes are in a hydrophobic environment, the quantum 
yield is much higher and the wavelength of maximum fluorescence shifts [24]. Therefore, 
it is possible to deduce when the probes bind to hydrophobic patches on the protein by 
monitoring the change in fluorescence. Although this method is simple, fast, and 
nondestructive, there are some concerns in regards to its reliability. The overall structure 
of the extrinsic dyes is quite diverse, where they can vary in size as well as aromatic, 
aliphatic, and charged functionalities. As a result, the mode of binding can be different 
between dyes, ultimately leading to differences in hydrophobicity values [25]. This is 
particularly important when we consider that charge-charge interactions may occur in 
some cases like the charged dye ANS, which could enhance or reduce its overall binding 
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affinity to the protein, influencing its estimation of hydrophobicity [17, 26]. As a result, the 
quantification of surface hydrophobicity may not be entirely accurate.  
 To conclude, both traditional techniques, fluorescence spectroscopy and 
hydrophobic interaction chromatography, have a number of experimental problems 
limiting their ability to provide an accurate value of hydrophobicity. Even then, the 
techniques only determine relative hydrophobicities, which do not provide any significant 
information of the protein’s hydrophobic character unless compared to another protein. 
Therefore, this stresses the importance of establishing a multi-method quantitative 
measurement protocol to define surface hydrophobicity. 
 The alternative method that we will explore is the use of NMR to determine the 
surface hydrophobicity of proteins. NMR is a sensitive and robust technique that can be 
used to study the binding between a small molecule (probe) and a larger macromolecule 
(protein) by observing the transverse relaxation time (T2) [27]. Though the concept is not 
novel considering that drug screening by NMR has been a common approach for drug 
design, where fragment based drug design focuses on finding small molecule binders in 
specific locations on the protein [28], the investigation proposed here has a novel 
application by studying the interactions of small hydrophobic probes to proteins. The idea 
is to use an excess amount of small molecular probe, which would allow it to 
nonspecifically bind to many different locations of the protein. By selectively using 
hydrophobic probes, we can then deduce the overall surface hydrophobicity of the protein 
by analyzing the extent of binding. The benefit of using NMR is that we would be able to 
conduct experiments in buffers matching formulation and storage conditions (unlike HIC) 
while being unrestricted to the use of only aromatic probes (unlike fluorescence). 
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 In this study, the sensitivity of NMR to measure surface hydrophobicity was 
explored by comparing the extent of binding between various probes and protein 
standards. The probes utilized were chosen based on the aliphatic or aromatic features. 
The results determined by NMR would be corroborated with HIC and fluorescence to 
further substantiate our findings.    
 
4.2 – Materials and Methods 
Materials 
Bovine Serum Albumin (BSA), α-Chymotrypsinogen A from Bovine Pancreas (A-
ChytA), and β-Lactoglobulin A (B-LgA) from Bovine Milk, N-Acetyl-L-Leucine Methyl Ester 
and N-Acetyl-L-Phenylalanine Ethyl Ester were purchased from Sigma (St. Louis, Mo). 
Acetyl-Valine-Methyl Ester was purchased from Bachem Americas Inc., N-Acetyl-L-
tryptophan Ethyl Ester was purchased from TCI Chemicals and N-Acetyl-L-Tyrosine Ethyl 
Ester was purchased from MP Biomedicals, LLC. ANS (8-anilino-1-naphthalenesulfonic 
acid) was purchased from Molecular Probes. The Hiscreen Butyl HP column and 
Hiscreen Phenyl HP column was purchased from GE Healthcare. Solutions were 
prepared in a sonicated 15 mM ionic strength (8.5 buffer strength) phosphate buffer (pH 
7.0). All buffers and protein stock solutions were filtered through 0.22 μm filters.  
 
Sample Preparation 
All samples were prepared in the same buffer (8.5 mM sodium phosphate, 15mM 
ionic strength, pH 7.0, and ~90% D2O) using nitrogen flushed D2O. The probe 
concentration was held constant at 3 mM, where molar ratios of 1:20, 1:50, 1:100, 1:150, 
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1:200, 1:400, and 1:1000 correspond to 150 µM, 60 µM, 30 µM, 20 µM, 15 µM, 7.5 µM, 
and 3 µM of protein (BSA, A-ChytA, or B-LgA), respectively. A 1:50 ratio was used (1.5 
mM probe and 30 µM protein) for comparative studies between probes. The probes were 
also investigated alone at the concentrations of 1.5 mM, 3 mM, or 6 mM. None of the 
samples contained any reference compounds due to initial observations that internal 
references can also bind to the protein targets, which skew the measurements, while 
external references significantly complicated the acquisition process due to the problems 
associated with shimming of two different compartments simultaneously.  
The probes selected to be tested belong to two major subclasses of compounds: 
aliphatics and aromatics. The aliphatics consisted of tert-butyl alcohol, 1-propanol, and 1-
butanol whereas only phenol was used as an aromatic. In addition, capped amino acids 
were selected to mimic protein-protein interactions. Similarly, the capped amino acids 
were chosen based on their aliphatic and aromatic side chains, with the aliphatics being 
N-acetyl-L-leucine methyl ester, and N-acetyl-L-valine methyl ester, and the aromatics 
were N-acetyl-L-phenylalanine ethyl ester, N-acetyl-L-tryptophan ethyl ester, and N-
acetyl-L-tyrosine ethyl ester.  
 
Measuring Transverse Relaxation Time 
The binding of the probe to the protein was determined by measuring the 
transverse relaxation time (T2) of the probe. Samples were prepared in 535-PP-7 NMR 
tubes purchased from Wilmad Labglass (Vineland, NJ) and experiments were performed 
at 25 °C. The water signal was suppressed by presaturation at power level of 6 dB for 3 
seconds. The T2 was acquired from array experiments performed by using the Carr-
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Purcell-Meiboom-Gill (CPMG) T2 pulse sequence without temperature compensation 
[29]. The acquisition delay was set to 25 seconds, no sample heating was observed under 
these conditions as judged by the lack of temperature-dependent perturbations in 
chemical shifts. No alterations in peaks shapes due to J-coupling [30] was noticed either. 
The bigtau parameter, which is the time between the initial pulse and data acquisition, 
was non-uniformly distributed with larger bias to the smaller time values to improve 
exponential fit. The bigtau sets were not identical between experiments due to the 
variability of the relaxation of the probes (see Table 4.1 for bigtau sets).  
The integral for the probe peak of interest was taken in each spectrum of the array. 
Errors originating from overlapping peaks were minimized by base-line correction, which 
involves subtracting a spectrum of the protein alone from the spectrum of the probe with 
additional correction factors to account for concentration differences. The intensities for 
the peak of interest were also taken and used to compare exponential fitting parameters 
(see supporting information). The fit was carried out using the VnmrJ v3.2 T2 analysis 
module. The equation used for the fit was: 
     𝑦 = 𝑚0 ∗ 𝑒
(
−𝑥
𝑇2
)
+ 𝑚1   (1) 
m0 is a constant that corrects for the scaling factor of the integral and m1 is a constant 
that corrects for baseline issues. The T2 measurements were done in triplicates on a 
Varian 600 MHz spectrometer equipped with a triple resonance cryogenic probe.  The 
average T2 was calculated for further analysis. 
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Table 4.1. Big Tau Sets for Determining Transverse Relaxation Time 
Probe Protein BigTau Set (s) 
Tert-butyl 
alcohol 
None 
B-LgA 
A-ChytA 
0.1,0.2,0.4,0.6,0.8,1.2,2,3,4,6,8,12,20 
Tert-butyl 
alcohol 
BSA 0.1,0.2,0.4,0.8,1.2,2,3.5,6,8 
Butanol None 
BSA 
B-LgA 
A-ChytA 
0.2,0.3,0.5,0.7,1.2,2,3.5,5.5,8,12 
butanol BSA 0.1,0.2,0.3,0.5,0.7,1.2,2,3,4.5,6 
propanol None 
B-LgA 
A-ChytA 
0.2,0.4,0.6,0.8,1.2,3,6,9,12,20 
propanol BSA 0.1,0.2,0.3,0.5,0.7,1.2,2,3,4.5,6 
phenol None 
B-LgA 
A-ChytA 
0.2,0.5,0.8,1.2,2,4,6,12,24 
phenol BSA 0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5 
Leu None 
B-LgA 
A-ChytA 
0.1,0.2,0.4,0.8,1.2,2,4,8,16 
Leu BSA 0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5 
Val None 
BSA 
B-LgA 
A-ChytA 
0.1,0.2,0.4,0.8,1.2,2,4,8,16 
Phe None 
B-LgA 
A-ChytA 
0.1,0.2,0.4,0.8,1.2,2,4,8,16 
Phe BSA 0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5 
Trp None 
B-LgA 
A-ChytA 
0.1,0.2,0.4,0.8,1.2,2,4,8,16 
Trp BSA 0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5 
Tyr None 
B-LgA 
A-ChytA 
0.1,0.2,0.4,0.8,1.2,2,4,8,16 
Tyr BSA 0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5 
The minimum number of points used was 9 and experiments performed at different 
concentrations (if applicable) all used the same bigtau set. The above table indicates the 
combination of protein and probe and their respective bigtau set.  
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Measuring the Diffusion Coefficient by DOSY 
 Preparation of the sample was identical to methods mentioned previously. The 
sample was subjected to a pulse sequence of diffusion correlation spectroscopy (DOSY) 
called DgcsteSL (DOSY Gradient Stimulated Echo with Spin Lock). For the experimental 
parameters, the diffusion delay (del) is 60 ms, total diffusion-encoding pulse width (gt1) 
is 2 ms, gradient stabilization delay (gstab) is 0.2 ms, relaxation delay is 10 s, and number 
of increments was 15 (values of the gradient level are randomly selected between 1300 
and 32500 by the software). The integral area of the signal of interest was used to 
calculate the diffusion coefficient through the VnmrJ v3.2 DOSY module.    
 
4.3 – Results and Discussion 
4.3.1 – Experimental Considerations 
 Though NMR is a useful technique for analyzing both small ligands and proteins, 
utilizing NMR as a quantitative tool requires extra care. Proper calibration should be and 
needs to be done (ex - 90o pulse width) on each individual sample due to sample 
variability. The next consideration is the presence of H2O as the experiments are 
performed in an aqueous environment. Ideally, the percentage of D2O should be close to 
100%, but would be difficult to achieve as it would require the use of deuterated buffering 
agents as well as proteins as the amide proton is labile. The buffer itself is made by using 
D2O as the solvent, which is how we estimated that the amount of D2O is approximately 
90%. 
 The reason as to why H2O is important to consider is because its concentration far 
exceeds the concentration of the probe/proteins in solution. Given that the experiment is 
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a simple 1H-CPMG T2, we would observe a signal for water. It would be the dominant 
peak by a far margin and would make it unsuitable to observe probe peaks close to 4.7 
ppm due to spectral overlap. The suppression of the water signal needs to be done to 
obtain a proper baseline, which is achieved by a presaturation pulse prior to the excitation 
of the protons. The power of the presaturation pulse has to be as minimal as possible so 
that it would not affect the peak of interest. 
 The confidence in the T2 values obtained can be improved by the use of a 
reference compound, which would indicate if the parameters of the experiment were 
adequately calibrated as the reference T2 and chemical shift should be the same between 
runs. The reference compound can be added into the solution itself (internal reference) 
or in a secondary compartment separate from the solution (external reference). Though 
an internal reference would be straightforward as it simply requires the addition of equal 
volumes of reference compounds into every sample, a problem arises when the reference 
compound is not inert. That is, the reference compound is able to interact with the solution 
components like the protein. This is observed in our initial tests in which we tested the 
binding of tert-butyl alcohol and BSA at two different ratios (Table 4.2). As expected, the 
line width of tert-butyl was broadened, which is indicative of binding. However, we see 
that our internal reference, 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), also 
showed line broadening. This makes it difficult to properly assess the extent of binding of 
tert-butyl alcohol if there are multiple ligands that may or may not bind to the same 
interface. Though it is possible to utilize internal references, it requires prescreens to 
determine if the compound is truly inert, which can become cumbersome if you are 
screening against a large number of proteins. 
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Table 4.2. Line Width Variability with an Internal Reference 
 
 Line width of 
Tert-butyl alcohol (Hz) 
Line width of DSS (Hz) 
No protein 2.96 2.99 
1:100 BSA:tert-butyl 3.64 5.54 
1:50 BSA:tert-butyl 4.41 6.43 
The line width of tert-butyl alcohol peak (at 1.23 ppm) and DSS (at 0.0 ppm) were 
calculated at half height in the presence and absence of BSA. The concentration of DSS 
and BSA were held constant at 2 mM and 29 µM, respectively. The concentration of tert-
butyl alcohol was 3 mM for the no protein and 1:100 sample while being reduced to 1.5 
mM for the 1:50 sample.    
 
 
 
The alternative solution is to use an external reference. The benefits are easily 
visible as the external reference has no capability of interacting with the protein and can 
be removed and reused for a different sample, which means that the external reference 
is identical between runs/samples. The downside is that the sample contains two different 
compartments of two closely matched, but not identical solution composition. As such, it 
becomes troublesome to create a proper homogenized magnetic field, leading to 
potentially distorted line shapes. This makes the process for collecting the data much 
more tedious especially if the external reference is improperly aligned in the center. As a 
result, the T2 experiments performed here were done in the absence of a reference 
compound. However, the use of an external references have been used for quantitative 
purposes as reported in the literature [29-32] and has given reasonable results for DOSY 
using a Wilmad coaxial insert.  
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 Lastly, the goal of this study is to investigate the extent of hydrophobic interactions 
of small probes with a protein standard. Unfortunately, the experiments have to be done 
in aqueous solutions so that the proteins are properly folded and behaving normally. This 
means that the use of entirely hydrophobic compounds, such as benzene or butane, is 
not feasible due to their low solubility. Thus, it is necessary that our compounds contain 
a hydroxyl group for increased solubility (ex – phenol and butanol). As a result, there is a 
caveat that the interaction may not be completely hydrophobic. 
 
4.3.2 – Line width versus Transverse Relaxation Time 
 In order to determine if a small molecular weight probe interacts with a larger 
macromolecule target, such as protein or DNA, it is possible to track changes in the probe 
relaxation rate through nuclear magnetic resonance (NMR) spectroscopy [33-35]. Large 
molecules will have longer correlation times and relax faster in solution, which is important 
because binding of the probe to the protein will result in a faster relaxation rate for the 
probe [36]. The parameter, which correlates with relaxation rates of molecules and could 
be directly derived from any NMR spectrum, is the line-width of the molecules’ 
corresponding peaks. The true line-width and T2, the transverse relaxation time, are 
related by the equation: 
                                                          𝜗1 2⁄ =
1
𝜋𝑇2
                                (2) 
thus, indicating the plausibility to use either line-width or T2 to monitor the binding of the 
probe to the protein. However, in our initial attempt to develop a general method for 
measuring weak non-specific probe interactions with hydrophobic surface areas of 
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proteins, we have found out that line-width was not an optimal parameter to use. In 
practice, the measured line-width is affected by artifacts as shown by the equation: 
                                               𝜗𝑎𝑐𝑡𝑢𝑎𝑙 = 𝜗1 2⁄ + 𝜗𝑛𝑜𝑛−ℎ𝑜𝑚                  (3) 
The large errors in line-width measurements are predominantly associated with magnetic 
field non-homogeneity and are caused by difficulties achieving exactly the same shims 
between samples, which would overshadow the small difference in line-width that would 
arise from weak binding. From this perspective, measuring T2 is a better choice as it 
minimizes the problem of magnetic field inhomogeneity. The T2 relaxation was 
determined by fitting the data points (in form of peak integrals or intensities) in time array 
to equation 1 as shown by the example in Figure 4.1.  
  
4.3.3 – Intensity versus Integral 
There are two possible methods that can be used to observe the exponential decay 
of the peak of interest. This can be either done by monitoring the intensity of the peak at 
a certain chemical shift or by taking the integral of a defined region. There are several 
benefits of using integral over intensity. First, integrals are less error prone because 
random noise in the defined region will be predominantly canceled out. Second, intensity 
is more sensitive to a number of factors not particularly related to binding, such as the 
line shape and possible chemical shift changes due to temperature instability.30 Though 
integrals are more favorable to use over intensity, there are problems associated with 
overlapping peaks, especially in the case of broad protein peaks underneath the sharp 
probe peak. Integration over that region would combine the areas of both the signal of 
interest and those unwanted peaks, resulting in difficulties fitting the data and inaccurate 
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T2 measurements. It is necessary to do protein peaks subtraction before fitting for such 
cases where significant overlap is visible and it is not possible to choose probe peaks 
from other chemical shifts regions. An example of using integration to determine the T2 
relaxation time is shown in Figure 4.1, where the peak area is taken at different time 
intervals for the phenol triplet peak at 7.34 ppm. 
 
 
   
Figure 4.1. Representation of an Exponential Decay and Fit. A sample exponential 
decay (of 3 mM phenol) obtained from the CMPG-T2 experiment. The exponential is fit 
with the equation 1. The variables of the fit were m0 = 99.2, m1=0.88, and t2=5.147 s. 
The inset depicts the peak of interest (triplet at 7.34ppm) at consequent time points in the 
array. 
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4.3.4 – Analysis of T2 Binding 
 As the binding of the small probe is expected to be weak and non-specific (with a 
dissociation constant in the high mM range), it is reasonable to assume that the 
equilibrium between the free and bound state is in fast exchange (Lepre et al., 2004). 
Because of this, the analysis of the extent of binding becomes less complex, where the 
T2 observed is simply proportional to the populations of the free and bound states: 
                          
1
𝑇2𝑜𝑏𝑠
= 𝑓𝑏
1
𝑇2𝑏
+ (1 − 𝑓𝑏)
1
𝑇2𝑓𝑟𝑒𝑒
   where   𝑓𝑏 =
[𝑆𝑃]
[𝑆]𝑡𝑜𝑡𝑎𝑙
   (4) 
where T2obs is the T2 observed (probe in the presence of protein), T2b is the T2 of the 
bound state, which is assumed to be the T2 of the protein, T2free is the T2 of the free 
probe, and fb is the fraction of probe bound. The 1H transverse relaxation times of proteins 
were experimentally determined to be 0.030 s, 0.020 s, and 0.003 s for B-LgA, A-ChytA, 
and BSA, respectively. We can then solve for the amount of fraction bound, where the 
equation becomes: 
                                                    𝑓𝑏 =
𝑇2𝑏(𝑇2𝑓−𝑇2𝑜𝑏𝑠)
𝑇2𝑜𝑏𝑠(𝑇2𝑓−𝑇2𝑏)
                        (5) 
When we consider nonspecific interactions, the probe is likely to bind to multiple sites on 
the protein. To simplify matters, we assume that there are n equivalent binding sites, 
which gives use the binding model: 
                                                           
[𝑆𝑃]
[𝑃𝑜]
= 𝑛 (
[𝑆]
[𝑆+𝐾𝑑]
)                          (6) 
We can rearrange equation 6 to include the fraction bound to get: 
 
          𝑓𝑏 = 𝛼 − √(𝛼2 − 𝛽 )                           (7) 
where 
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                                                         𝛼 =
[𝑆]𝑜+𝑛[𝑃]𝑜+𝐾𝑑
2[𝑆]𝑜
                           (8) 
and 
                                                              𝛽 =
𝑛[𝑃]𝑜
[𝑆]𝑜
                                  (9) 
From this binding model, we can see that the T2 values obtained in the experiment can 
be used to determine the Kd, and n. However, this is highly dependent on how it is fit [37]  
and could lead to data over-interpretation due to multiple unknown variables. Thus, 
quantification of the binding becomes difficult and we opted to provide a semi-quantitative 
approach by comparing the fraction bounds of the probes instead.  
 
4.3.5 – Concentration Dependent Change in Fraction Bound 
 In order to investigate if fraction bound was a suitable measure for semi-
quantitative analysis, we conducted a series of T2 experiments at different ratios of probe 
to protein as exemplified in Figure 4.2. The two model probes (phenol and tert-butyl 
alcohol) were tested against BSA, A-ChytA, and B-LgA, where the probe concentration 
was held constant and the protein concentration was increased. As shown, the increase 
in protein concentration causes a linear increase in the proportion of the fraction bound, 
at least at concentrations where the probe is still in large excess. 
 If we were to provide a linear fit, the steepness could be considered as a semi-
quantitative measurement of protein hydrophobicity, where steeper slops are correlated 
to a larger degree of bound probe compared to a shallow slope. Thus, we can deduce 
that BSA is the most hydrophobic whereas B-LgA is the least based on phenol. Tert-butyl 
alcohol had less affinity for BSA than phenol and no significant association with A-ChytA 
and B-LgA.   
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Figure 4.2. Increasing Protein Concentration Results in a Larger Population of 
Fraction Bound. Plot showing the fraction bound of probe vs the concentration of protein. 
The probe:protein mixtures are labeled and a linear fit of each data set is shown. Two 
sets of data are shown for phenol:A-ChytA to better represent the variability of T2s 
obtained, which is due to protein degradation/activation at different time points of protein 
preparation.  
 
 
Also, Figure 4.2 illustrates that, the T2 measurements of phenol was fairly 
inconsistent in the presence of A-ChytA, which was quite surprising. Upon further 
investigation of A-ChytA’s behavior in solution, we found that it is most likely due to the 
propensity of A-ChytA to degrade/oligomerize over time, which could be potentially 
related to the autocatalysis from trace impurities of chymotrypsin [38]. Dr. Zecca also 
performed time based analysis of A-ChytA and determined that A-ChytA does degrade 
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over time and begins to degrade within a day. Thus, it is imperative that proteins are 
prepared fresh to minimize artifacts arising from degradation products. Alternatively, this 
could serve as a basis for determining if there are any changes in sample integrity. 
 Lastly, investigation of probe-protein interactions at a multitude of ratios can be 
time consuming. To streamline the process, we opted to investigate the differences of 
fraction bound at a particular ratio. As seen in Figure 4.2, there are noticeable differences 
in the individual fraction bounds at a particular ratio, but this approach requires that there 
is a sufficient amount of probe bound to have more confidence in the measured 
differences in the T2 and fraction bound values. For this, we chose the 1:50 ratio and 
prepared fresh samples for all subsequent experiments. 
 
4.3.6 – Comparison of Aliphatic and Aromatic Probes 
 As previously shown by the concentration dependent changes in the fraction 
bound, the extent of phenol binding to the protein standards was much higher in 
comparison to tert-butyl alcohol, suggesting that these interactions are not equivalent. 
This is further extended to include additional probes as shown in Table 4.3, which 
encompasses more aliphatic probes. Though we were not able to find another suitable 
aromatic probe (preliminary tests with benzyl alcohol showed an irregular chemical shift 
pattern with multiple unique proton peaks overlapping, which is not ideal for peak analysis 
through integration or intensity), the results showed similar patterns with tert-butyl alcohol, 
where 1-propanol and 1-butanol interacted with BSA. The percent decrease in the T2 was 
fairly higher for 1-propanol (60%) and 1-butanol (73%) in comparison to tert-butyl (21%). 
Likewise, there was no perceptible binding of the aliphatic probes to either A-ChytA or B- 
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Table 4.3. Percent Reduction in T2 Relaxation Times of the Probes upon Binding 
to the Proteins. 
                  Protein 
 
Probe 
 
BSA 
 
A-ChytA 
 
B-LgA 
Tert-butyl alcohol 21 NB NB 
1-butanol 73 NB NB 
1-propanol 60 NB NB 
Phenol 97 11 18 
Capped Amino Acids 
Leucine 58 9 NB 
Valine 17 NB NB 
Phenylalanine 84 NB 8 
Tryptophan 94 21 19 
Tyrosine 79 6 NB 
The values shown above are the percent reduction in T2 when compared to the T2 of the 
free probe using the average T2 value obtained, where percent change = 100 ∗ (𝑇2𝑓 −
𝑇2𝑜𝑏𝑠)/𝑇2𝑓. Percent changes of less than 5% were within experimental error and are 
denoted with NB (no binding). The ratio for protein:probe is 1:50, where the protein 
concentration is 0.03 mM and the probe is 1.5 mM. T2 of the free probes and integration 
regions are: tert-butyl alcohol = 2.32s (1.28-1.18ppm), 1-butanol = 2.69 s (0.86-0.6 ppm), 
1-propanol = 3.32 s (0.86-0.6 ppm), phenol = 5.16 s (7.4-7.26 ppm), leucine = 0.67 s 
(0.84-0.7 ppm), valine = 0.83 s (0.95-0.6 ppm), phenylalanine = 2.04 s (7.28-7.08 ppm), 
tryptophan = 2.20 s (7.56-7.45 ppm), tyrosine = 1.46 s (7.14-6.86 ppm).  
 
 
 
LgA. On the contrary, phenol does interact with all three proteins and had a significant 
drop in T2 in the presence of BSA (97%), leading to a hydrophobicity order from most to 
least: 
BSA > B-LgA > A ChytA 
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4.3.7 – Usage of Capped Amino Acids as Probes 
 As the goal of this study is to determine the surface hydrophobicity and attempt to 
correlate that to how proteins/antibodies behave in solution, we expanded the library of 
probes to include amino acids. The amino acids normally have charged ends due to the 
amino and carboxylic acid functional groups, so it was necessary to utilized capped amino 
acids, where the amino group is acetylated and the carboxylate is methylated. With the 
charges neutralized, we focused on the interaction of the side chains. Table 4.3 shows a 
similar pattern to our small molecular probes, where the aromatic amino acids have a 
large decrease in their T2 values in the presence of BSA in comparison to the aliphatic 
amino acids. The aliphatic amino acids exhibited no binding to A-ChytA or B-LgA. The 
9% decrease for Leu can be attributed to its low T2 (0.67 s alone and 0.61 s in the 
presence of A-ChytA).  
 On the other hand, the aromatic amino acids were expected to interact with both 
A-ChytA and B-LgA due to similarities with phenol. Trp bound to both proteins, but both 
Tyr and Phe showed weak or no binding. Due to the inconsistencies in the T2, we 
questioned the reliability of these capped amino acids as probes. Since the side chains 
are most likely not the factor, we hypothesized that the capped C- and N-termini were 
responsible, which would be due to increased bulkiness and more steric hindrance.  
 Furthermore, we found that different conformations of capped amino acids exists 
in solution. In general, the different conformations of a compound are readily 
interconverted in solution, so the corresponding peaks in the 1H NMR spectrum represent 
an average of the conformations. However, we found that capped amino acids have 
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different conformations in slow exchange, leading to at least two distinct conformations 
of non-equal populations. This is demonstrated in Figure 4.3, which depicts the aromatic 
region of the 1H spectrum for Trp. Since Trp only has five unique aromatic protons, we 
can conclude that there are multiple conformations of Trp as manifested by the more 
complex pattern of peaks. The integrations of the peaks (as described in the figure 
legend) suggests that it is indeed five protons. 
 This is further complicated because each individual conformation behaves 
differently in solution as observed by the differential binding patterns (Figure 4.3). If we 
were to focus on the left most hydrogen, we see that the left doublet at 7.54 ppm in the 
presence of BSA and partially disappears with B-LgA, but remains with A-ChytA. 
Conversely, the right doublet at 7.48 ppm disappears in the presence of A-ChytA, but not 
BSA or B-LgA. This is highly undesirable as the exponential fit is complicated due to the 
differing binding capacities of individual conformations, which then necessitates the use 
of a multiple exponential fit rather than a single exponential. For example, taking the 
integral over the range from 7.56 ppm to 7.45 ppm to examine the T2 of one hydrogen 
would no longer be appropriate for analysis by equation 1 due to the presence of multiple 
unique protons.  
Thus, the T2 values defined from these experiments becomes questionable. 
Though this interaction-based conformational heterogeneity is interesting on its own 
terms, it serves little purpose to the goal at hand. Based on these findings, we concluded 
that Trp is not an appropriate probe to use. Furthermore, different conformations were 
also observed for Leu and Tyr, but not Phe and Val. Though Phe and val do not explicitly  
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Figure 4.3. Conformations of Trp and their Behavior in the Presence of Proteins. 
Capped-Trp spectra are shown zoomed on the aromatic region. The concentrations of 
Trp (shown for Trp alone in A) are 3 mM and the ratio of Trp to proteins, (shown for BSA 
in (B), for A-ChytA in (C), and for B-LgA in (D)), is 1:100. Integration areas are: 7.56-7.45 
ppm = 0.99, 7.4-7.3 ppm = 1.02, 7.15-7.06 ppm = 2.0, 7.05-6.98 ppm = 0.99. This 
correlates to the five aromatic protons of Trp. 
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show different conformations within the NMR spectra, it is better to err on the side of 
caution and avoid their use.     
 
4.3.8 – Applicability of DOSY 
 Since we had found that T2 is a reasonable parameter for determination of the 
surface hydrophobicity of a protein, we investigated the possibility of using an alternative 
parameter to quantify the interaction between the probe and protein. The purpose of this 
was to replicate our findings in a different experiment to corroborate the surface 
hydrophobicity. For this, we opted to look at the diffusion coefficient, which would be 
determined through DOSY. The analysis of the diffusion coefficient is highly similar to T2, 
where the probe/protein complex are in fast exchange, leading to the dependence of the 
observed diffusion coefficient on the populations of the free and bound states: 
                                               𝐷𝑜𝑏𝑠 = 𝑓𝑏𝐷𝑏 + (1 − 𝑓𝑏)𝐷𝑓𝑟𝑒𝑒         (10) 
where Dobs is the observed diffusion coefficient of the probe in the presence of protein, Db 
is the diffusion coefficient of the bound state, fb is the fraction of probe bound, and Dfree is 
the diffusion coefficient of the free probe.  
 Though we had hoped that the diffusion coefficient would provide similar results to 
our T2 experiments, the conclusion was that DOSY was not an adequate approach for 
investigating weak interactions. As presented in Table 4.4, the change on the diffusion 
coefficient of phenol in the presence and absence of proteins. The most significant 
change is anticipated to be with BSA, which showed a 97% decrease in T2. Here, we see 
that the diffusion coefficient dropped from 3.74x10-10 m2/s to 3.59x10-10 m2/s, which  
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Table 4.4. Determination of Diffusion Coefficients. 
 
Sample Diffusion coefficient (10e-10 m2/s) 
Phenol Only 3.7400 
Phenol + BSA 3.5940 
Tert-butyl alcohol Only 3.1794 
Tert-butyl alcohol + BSA 3.0922 
DSS 2.3821±0.022 
The diffusion coefficient of the samples were calculated by peak integration (phenol = 
7.4-7.26 ppm, tert-butyl = 1.28-1.18 ppm, DSS = 0.05--0.05 ppm). The concentrations 
were 3 mM for BSA and 1.5 mM for the probe. The concentration of DSS (in an external 
compartment) was 5 mM. The external reference was reused for multiple runs for 
calibration and test runs, which is how the diffusion coefficient and standard deviation of 
DSS was calculated (n = 16). No error is given for the other runs as they were only run 
once. 
 
 
amounts to a 4% decrease. This drop is very modest and falls close to experimental error. 
Though the probe/protein experiments were only run once as a test, we also analyzed 
the diffusion coefficient of DSS a multitude of times (n= 16), which was determined from 
be 2.382 ± 0.022 x10-10 m2/s, where the error itself amounts to ~1%. Though the 
difference is above the error, the difference is still minimal, which means that it further 
experiments would require a lower probe:protein ratio like 1:20 rather than 1:50. However, 
lower ratios are more problematic due to either the lower signal to noise of the probe 
(lower probe concentration) or more protein spectral overlap (higher protein 
concentration).  
 To understand what the problem could have been, we theoretically determined the 
diffusion coefficient of the protein (Db) based on the Stokes-Einstein equation [39]: 
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                                                                𝐷 =
𝑘𝑇
6𝜋𝜂𝑟𝐻
                                       (11) 
 where the diffusion coefficient, D, depends on the Boltzmann constant (k), temperature 
(T), viscosity (η), and the hydrodynamic radius (rH). The hydrodynamic radius of a protein 
is variable, but we can simply assume that it adopts a spherical shape for this calculation, 
which means that the minimum radius [40], assuming the specific volume of a protein is 
0.73 cm3/g, is: 
                                                      𝑅𝑚𝑖𝑛 = 0.066√𝑀
3
                            (12) 
where Rmin is related to the cubic root of the molecular weight (M). Once we plug in the 
values, we see that the estimated Db for BSA is 0.915 x 10-10 m2/s, which is markedly 
close to the Dfree of phenol. This is most likely the reason why the effect of binding is 
minimal for DOSY as the difference between the Dfree and Db is much smaller than T2free 
and T2b. Thus, we were unable to use DOSY to validate our T2 experiments. 
 
4.3.9 – Correlation with HIC and Fluorescence 
 Though DOSY was not an effective method for this project, investigation of the 
surface hydrophobicity by Dr. Zecca through HIC and Fluorescence showed promising 
results. The hydrophobicity order, from most to least, that was established by NMR was 
BSA > B-LgA > A-ChytA with phenol as the probe. 
 For fluorescence, an extrinsic fluorescence probe ANS was used, where its 
quantum yield and wavelength of maximum fluorescence depends on if it is present in an 
aqueous or hydrophobic environment. Through this, it was determined that the surface 
hydrophobicity (measured by the initial slope S0 as shown in Table 4.5) order was BSA > 
B-LgA > A-ChytA, which coincides well with our NMR data. This is further validated 
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Table 4.5. Initial slopes (S0) of ANS bound to BSA, B-LgA and A-ChytA. 
Protein Surface Hydrophobicity (S0) 
BSA 1355.2 
B-LgA 15.4 
A-ChytA 2.8 
The initial slope of the relative fluorescence intensity (RFI) at 470 nm is shown above for 
each individual protein with ANS as the extrinsic dye, where the initial slope is 
representative of the surface hydrophobicity.  
 
Figure 4.4. HIC Elution Profiles. The HIC elution profiles of BSA, A-ChytA, B-LgA, and 
Mixture on (A) Phenyl HP or (B) Butyl HP column are shown above, where the proteins 
were detected by monitoring the absorbance and 280 nm. The gradient was a 30 minute 
linear gradient of 1.0 M to 0.0 M ammonium sulfate in 20 mM sodium phosphate at a 0.5 
mL/min flow rate. The column was continually washed with 20 mM sodium phosphate 
after 30 minutes to allow all the protein to elute and the baseline to return to normal.   
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through HIC, where the protein is subjected to an immobilized hydrophobic phase. The 
more hydrophobic proteins would remain bound to the column and would be difficult to 
elute, so that the elution profile would give an indication as to the relative hydrophobicities 
of the proteins. In Figure 4.4, the retention times showed that the hydrophobicity orders 
were similar, where A-ChytA was the least hydrophobic and BSA was the most. The order 
was the same when we utilized an immobilized aliphatic (butyl) or aromatic (phenyl) 
phase. 
 The elution profiles do show that there are multiple peaks, indicating heterogeneity 
in the sample arising from fragments/aggregates or different conformations. This behavior 
could potentially be attributed to the ammonium sulfate concentration and/or the strength 
of the hydrophobic stationary column [41]. In particularly, BSA has been reported to 
change conformations upon binding to a butyl HP column and unfolded proteins are 
difficult to elute off, resulting in broader peaks [42]. Therefore, it is difficult to assess the 
overall extent of aliphatic and aromatic interactions due to these caveats. However, we 
do observe that there are distinct differences in the overall elution pattern. B-LgA has a 
relatively sharper peak for the phenyl column, which could be due to stronger π-π 
interactions. On the other hand, A-ChytA has multiple peaks for both column, but 
possesses an additional peak for the phenyl column [43], implicating that there is a 
difference when comparing aliphatic and aromatic interactions, which coincides with what 
we observed with NMR. 
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4.4 – Conclusion 
We experimentally determined the order of hydrophobicity to be BSA > B-LgA > 
A-ChytA, from most to least by NMR, HIC, and Fluorescence. This helps to prove that 
solution NMR is a fast and robust technique that is able to investigate the interaction 
between small molecular probes and proteins, where aliphatic and aromatic probes were 
determined to have differences in the non-specific binding capabilities. The use of capped 
amino acids revealed that the amino acids had multiple conformations, which is most 
likely due to the bulkier capped ends. Therefore, it is advised to not use capped amino 
acids despite its potential for mimicking protein-protein interactions.  
Though we see hydrophobicity order matches between the three techniques 
utilized, there still remains questions that need to be answered. For instance, further 
studies are needed to better characterize phenol as an optimal binding probe (or possibly 
find another small aromatic probe), to determine a suitable method for quantification of 
surface hydrophobicity by NMR, to understand how and when aliphatic probes bind, how 
sample integrity relates to the observed differences T2, and to characterize monoclonal 
antibodies, whom are industrially relevant. Nonetheless, we feel that NMR is a versatile 
technique that is suitable for measuring surface hydrophobicity in which we hope can be 
used as a predictive measure for protein behavior in solution.  
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Chapter 5 – Summary and Conclusions 
 
 The work presented in this dissertation has covered a wide range of goals and 
biological systems. However, the core that ties them all together is that investigation 
protein-protein and protein-ligand interactions are crucial for understanding structural 
features/changes as well as their functional role in vivo.  
 Chapter 2 explores the interaction between CD47 and PLIC-2 as a novel protein 
complex that could be related to how CD47 ultimately modulates the cytoskeleton. 
However, the in vitro results using the isolated domains of PLIC-2 and the cytoplasmic 
tail of CD47 isoform proved to be fruitless, where no detectable interaction was 
observed through ITC or NMR. The addition of a membrane mimetic (nanodiscs) did not 
provide positive results. On the other hand, PLIC-2, also known as ubiquilin-2, was 
shown to be able to self-associate (UBA/UBL complex) as well as bind to ubiquitin 
through its UBA domain, which is in line with the literature that have shown ubiquilin’s 
role in ubiquitin mediated protein degradation. Though it is unlikely that CD47 and PLIC-
2 associate, it may be reasonable to test other constructs (full length PLIC-2, full length 
CD47, CD47/integrin complexes). The additional residues could be a requirement for 
interacting, especially considering that our in vitro experiments may not be an ideal 
representation of in vivo conditions.   
 Chapter 3 investigates the activation mechanism of BTN3A1, who responds to 
intracellular pAg in order to activate Vγ9Vδ2 T cells. Association of the B30.2 and 
HMBPP causes minimal changes in the B30.2 domain based on the crystal structure, 
but there was an apparent change with the JM region by NMR. Further investigation of 
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the JM region specifically showed that the JM is able to interact with negatively charged 
diphosphate molecules in which two threonines were identified to be important. The 
binding itself was weak, but was corroborated with SAXS, ITC, and cellular assays. 
Therefore, this conformational change upon ligand association is particularly interesting 
to understand how pAg can activate BTN3A1. The data provided here does not provide 
a clear picture of the molecular details and binding interfaces as well as if this 
conformational change directly influences the conformation of its extracellular domain 
and/or binding affinity towards other protein partners. These questions will have to be 
addressed in future endeavors. 
 Chapter 4 involves the use of small hydrophobic probes as a means for 
evaluating the surface hydrophobicity of a protein through NMR. The work here 
explores the limitations and benefits of T2 as a quantitative method. The results show 
that the probes are able to interact with the protein, leading to a depression in their 
observed T2 value. The hydrophobicity order determined by phenol was consistent with 
current standards (HIC and fluorescence). To improve upon what has been done, it 
would be beneficial to expand the protein library and to include monoclonal antibodies, 
identifying how and when aliphatic/aromatic probes would bind, and correlation to 
solution properties, such as aggregation.  
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Appendix Chapter A1 – A Structural Model of the 
Skelemin and Integrin αIIbβ3 Complex 
 
Adapted from: Gorbatyuk, V., Nguyen, K., Podolnikova, N., Deshmukh, L., Lin, X., 
Ugarova, T., and Vinogradova, O. Skelemin Association with aIIbβ3 Integrin: A Structural 
Model, Biochem., 2014, 53: 6766-6775. 
 
A1 – Introduction 
 It has been known that cell adhesion is primarily mediated by integrins1 by which 
it connects the extracellular matrix to the cytoskeleton. It begins with the clustering of 
proteins to form a small network called motility induced focal complexes (FXs), which 
could ultimately be replaced by focal adhesions (FAs) in fully spread cells2. However, 
understanding the formation and components of FXs and FAs is crucial to understanding 
how the cells regulate cellular adhesion. The work presented in this chapter focuses on 
the role of skelemin, which is a protein found to be localized with FXs, but not FAs3.  
 Skelemin, also known as myomesin 1.1, is a 185 kDa muscle M-line cytoskeletal 
protein that is predominantly expressed in embryonic heart4, playing a crucial role in the 
early stages of cell spreading5. Skelemin is comprised of a unique N-terminal myosin 
binding domain, 5 fibronectin (FN) type III like domains, 6 immunoglobulin like C2 
domains (IgC2), and a C-terminal immunoglobulin domain responsible for dimerization6 
as shown in Figure A1.  The importance of skelemin in understanding FXs is that it has 
been shown that its IgC2 domains 4 and 5, hereafter referred to as Sk45, directly  
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Figure A1. Simplistic Diagram of Skelemin’s Domains. It consists of a unique N-
terminal myosin binding domain (MBD), seven IgC2, and five FN Type III-like domains. 
The IgC2 domains are numbered (shown within the ellipse) to more easily visualize the 
location of IgC2 domains 4 and 5.  
 
 
associated with the cytoplasmic tail of integrin β3 and integrin αIIb7,8. Considering that 
integrin exists as a heterodimer of α and β subunits, this lends itself to the proposition that 
Sk45 is able to simultaneously bind to both integrin subunits, in which it may then 
modulate the cytoskeleton through contractile force and/or the recruitment of other 
cytoskeletal proteins to the integrin cluster9. Given that there is evidence that skelemin is 
crucial for cell spreading and is able to associate with both integrin αIIb and β3, the goal of 
the chapter presented here aims to deduce the overall structure of the skelemin and 
integrin complex. 
 
A2 – Materials and Methods 
Mutagenesis, Expression, and Purification 
 For these experiments, mouse skelemin was cloned into E. coli. Single site 
mutagenesis of Sk45 of K1424 to C was performed using the QuikChange kit (Agilent 
Technologies). The mutant plasmid was transformed into Rosetta (DE3) competent cells 
(EMD Millipore). Protein expression was carried out using LB or M9 minimal media with 
15NH4Cl as the sole nitrogen source at 37 oC. Cultures were grown to an OD600 of ~0.6 
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and induced with 1mM of IPTG. After 4 hours, the cells were collected by centrifugation. 
For purification, cells were resuspended in buffer (20 mM Tris, pH 8, 300 mM NaCl, 10 
mM imidazole, 1 mM DTT, 1mM PMSF, 1 tablet of complete protease inhibitor cocktail 
(Roche Applied Sciences) and lysed by passage through a French press (Thermo 
Electron). The supernatant was incubated with Ni-NTA agarose resin (Qiagen) and the 
protein was eluted with a buffer containing 20 mM Tris, pH 7.5, 300 mM NaCl, and 500 
mM imidazole. For cleavage of the His-tag, thrombin was added directly to the Ni-NTA 
column, where cleavage was done at 37 oC for 4 hours with periodic mixing (50 mM Tris, 
150 mM NaCl, 1 mM EDTA, pH 7.5). Thrombin was subsequently inhibited by the addition 
of equivalent amounts of PMSF. The eluate was further purified by size exclusion 
chromatography (16/60 Superdex 75 column, GE healthcare) in 50 mM NaCl, 20 mM 
KPO4, pH 6.8. 
 
Paramagnetic Relaxation Experiments 
NMR experiments were performed on uniformly 15N-labeled samples prepared in 
buffer containing 20 mM KPO4, pH 6.8, and 7% D2O. Spectra were recorded at 25 °C on 
Varian INOVA 600 MHz spectrometer equipped with cold probe. Paramagnetic relaxation 
enhancement (PRE) experiments were performed with Sk45 K1424C construct, where 
the solvent exposed K1424 was mutated to cysteine. The 1H-15N HSQC spectra were 
collected on the samples with and without 3-maleimido-PROXYL (m-PROXYL) spin label. 
The effect of the spin label on the signal intensities was estimated from the normalized 
intensity differences in the spectra with and without the spin label. 
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Isothermal Titration Calorimetry 
Isothermal Titration Calorimetry was performed on a low volume Nano ITC (TA 
Instruments). Peptides corresponding to integrin cytoplasmic tails were solubilized in the 
buffer 50mM NaCl, 20mM KPO4, and pH 6.8. All ITC experiments were performed at 
25oC, 300 rpm mixing, 300 seconds time intervals between injections, and 3µl injection 
volumes. The concentrations used are as follows: 2.5 mM C-terminal β3 and 0.175 mM 
Sk4, 1.3 mM N-terminal β3 and 0.177 mM Sk45, and 1.9 mM αIIb and 0.177 mM Sk45. 
The analysis of the data was done in NanoAnalyze Software (TA Instruments) suite using 
“Independent” model.  
 
A3 – Results and Discussion 
Table A1. Thermodynamic Analysis of the Association of Skelemin and Integrin 
by ITC 
Titrant C-terminal β3 N-terminal β3 αIIb 
Protein Sk4 Sk45 Sk45 
Kd (µM) 16.7 37.2 14.2 
∆G (kJ/mol) -27.3 -25.3 -27.7 
∆H (kJ/mol) -0.6 -1.7 -1.6 
-T∆S (kJ/mol) -26.6 -23.6 -26.1 
Stoichiometry, n 1.00 1.30 1.26 
 
Skelemin IgC domains 4 and 5 have been shown to interact with β3 cytoplasmic 
tail previously10. To address the mechanism of this interaction and to define the 
thermodynamic forces driving the process, we have employed ITC. We have used Sk4 
and Sk45 constructs titrated with either full length αIIb cytoplasmic tail or short synthetic 
peptides corresponding to β3 N-or C-termini. The results, summarized in Table A1, 
revealed very weak interactions, which were in the tens µM range, that were 
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predominantly driven by entropy. For all cases, the stoichiometry of interactions was 
found to be one. The data also depicts that the C-terminal region of β3 interacts with the 
fourth IgC domain (Sk4) whereas the N-terminal region of β3 likely interacts with the fifth 
IgC domain (Sk5). Sk5 was not able to be tested independently due to stability problems 
in the absence of the fourth IgC domain. 
 It is also important to note that the affinity of the cytoplasmic tails of αIIb and β3 is 
around 5 µM, which is stronger than their affinity towards skelemin. This supports the 
notion that skelemin serves as a modulator and not an activator of integrin, where 
skelemin is able to associate after integrin is activated and its cytoplasmic tails are 
separated. The hypothesis that skelemin is able to interact with both αIIb and β3 is further 
corroborated as αIIb and β3 had unique binding interfaces on Sk5 as determined by 
chemical shift perturbation experiments (performed by Dr. Deshmuhk). The residues of 
Sk5 identified were 1361, 1363 and 1394 for αIIb and 1368, 1370, 1372, 1374, 1382-1384, 
and 1411 for N-terminal β3. With this information, we were able to dock the cytoplasmic 
tails of αIIb and β3 onto Sk45 to provide a model system. 
 However, the structure of Sk45 was not yet solved from the NMR constraints 
obtained due to the fact that the Sk4 and Sk5 domains were connected by a flexible linker. 
This resulted in inadequate resolution of the orientation between the two domains due to 
the lack of long distance restraints, which was then tackled through the use of residual 
dipolar coupling (RDC) and paramagnetic relaxation enhancement (PRE) experiments. 
RDC data provided additional long distance restraints for the structure calculations, which 
were performed by Dr. Gorbatyuk. The potential structures were thinned out by their 
agreement with the PRE data (Figure A2), which showed that m-proxyl attached at  
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Figure A2. Visualization of PRE Affected Residues. Effects of m-proxyl on peak 
intensities of Sk45 were quantified by I ÷ Io, where I and Io is the intensity in the presence 
or absence of m-proxyl, respectively. Values closer to 0 represent highly affected 
residues. These changes are visualized on the crystal structure of human myomesin 
(PDB ID: 3RBS). Peaks that could not be quantified at colored black and the tag location 
(K1424C) is colored red. As shown, the residues that are mostly affected lies on Sk5 
(circled in red) and are in close proximity to K1424C.  
 
 
position 1237 of the Sk45 K1424C only had an effect on the residues within the Sk5 
domain. This suggests that the two domains are likely to be far apart, where it is unlikely 
for the Sk5 domain to fold back to be in proximity of the Sk4 domain. Thus, the end result 
is an ensemble of structures (PDB ID: 4V10) of skelemin in a fairly extended state.  
From there, the structure of Sk45 was used to dock the cytoplasmic tails of αIIb and β3 
through the HADDOCK webserver11, where the composite model is shown in Figure A3. 
The electrostatic potential was calculated by using Adaptive Poisson-Boltzmann Solver 
(APBS)12 and the pdb2pqr webserver13 using PARSE as the forcefield and PROPKA 
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Figure A3. Model of the Integrin/Skelemin Complex. (A) Model of tertiary 
integrin/skelemin complex by HADDOCK: Sk45 (tan), αIIb (green), and β3 (purple). The 
inset shows hydrogen bonding network. (B) Zoomed view of the binding interface with 
Sk5 (colored by electrostatic potential, where the gradient is -10 (red), 0 (white), and 10 
(blue)). (C) The tertiary complex is arbitrarily placed with respect to the lipid bilayer. Each 
side is shown to better visualize the binding pockets and potential orientation with the lipid 
bilayer. The inset depicts positively charged residues (colored in blue) that may interact 
with the lipid bilayer. 
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to assign protonation states. Based on this model, we see a number of van der-Waals 
interactions between αIIb and Sk5’s predominantly hydrophobic binding pocket. The major 
interactions are αIIb F992 and F993 side chains with I1392 and the side chain of αIIb W988 
making hydrophobic contacts with F1388, K1389 and, possibly, D1387 of IgC5. Additionally, a 
hydrogen bond is formed between K994 amine of αIIb and the backbone oxygen of A1343. 
On the other hand, the β3/skelemin interface is mostly based upon a network of 
hydrogen bonds between β3 N-terminus and Sk5 as well as the linker between Sk4 and 
Sk5. The electrostatic surface potential of the zoomed Sk5 region presented in Figure 
A3B helps to visualize mostly hydrophobic cleft on the left interacting with αIIb subunit and 
predominantly negatively charged binding site for β3 subunit on the right. N-terminal K716 
and K725 of β3 forms hydrogen bonds with the side chain of E1384 and the backbone oxygen 
of D1415, respectively. There are hydrophobic interactions between β3 H722 and the side 
chain carbons of Sk45 K1413 and E1368. From the skelemin side, Sk5 K1418 forms an 
extensive hydrogen bonding network, which includes β3 residues D723, through both the 
side chain and backbone oxygen, and β3 E726, through the side chain only. Two hydrogen 
bonds are found within skelemin linker helix: the side chain nitrogen of K1321 is connected 
to β3 N744 while E1328 oxygen interacts with the side chain amine of R736. Though there is 
no direct experimental evidence to pinpoint the residues involved for Sk4, the model 
demonstrates no major interactions between IgC4 and β3, with only a couple of 
hydrophobic contacts found between side chains of IgC4 residues E1293 and N1294 and β3 
A750. 
In Figure A3C, we also show the positioning of the tertiary complex with respect to 
the lipid bilayer. As presented, one potential arrangement is that the skelemin Ig domains 
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4 and 5 may be placed parallel to the membrane surface. With this, the αIIb subunit comes 
out of the membrane almost perpendicularly with its W988 side chain making contacts with 
lipid head-groups at the membrane-cytoplasm interface. Integrin β3 is arranged at a sharp 
acute angle with its K716 side chain making contacts with negatively charged patch on the 
surface of Sk5. The top surface of Sk5 contains positively charged residues, which could 
associate with the negatively charged lipid membrane.  
 Lastly, the structure of skelemin’s IgC domains were also solved by Pinotsis and 
colleagues14 for the human isoform by crystallography (PDB ID: 3RBS). The structures 
coincided well with our NMR structure, where they adopted a well-known IgC2-fold, 
containing seven β-strands in two β-sheets forming two β-sandwiches. However, the 
major difference between the crystal and NMR structure lies within the linker region 
between the IgC2 domains (Figure A4). As shown, the crystal structure found that the 
linker region is highly helical, which depicts that the linker is rigid. In our solution structure, 
the N-terminal region of the linker adopts a helical fold that rests upon the Sk4 domain, 
which coincides with evidence that the Ig domain/helix interface area is structurally 
conserved throughout other Ig tandem domains of myomesin-114. Strikingly, the C-
terminal region of the linker was found to be flexible in solution, which allows for larger 
spatial orientations between the two IgC2 domains. Nonetheless, the difference between 
the crystal and solution structure can depict the elasticity of skelemin, where the linker 
region can serve as the springs/sensors of mechanical force. This is in line with current 
evidence as it has been shown that myomesin has similar elastic properties as titin 
through atomic force microscopy14,15.  
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Figure A4. Comparison Between the NMR Ensemble and the Crystal Structure. The 
overlay of Sk45 NMR ensemble (the 20 lowest energy NMR structures with the two 
domains oriented by means of RDC data) with the X-ray structure of human homolog 
(PDB ID 3RBS). The NMR ensemble and the X-ray structure (violet) are superimposed 
over residues 1227-1327 (domain Sk4) and 1344-1427 (domain Sk5). The linker region 
is magnified and is shown in ribbon presentation for X-ray structure to highlight the 
difference in rigidity.  
 
 
A4 – Conclusion 
To conclude, we have determined by NMR a three dimensional structure of tandem 
IgC2-like domains 4 and 5 of skelemin, where the linker is less ordered / more dynamic 
than suggested by earlier X-ray studies of the human homolog myomesin-1. We show 
that interaction between skelemin and integrin cytoplasmic domain is weak and 
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predominantly entropy driven, consistent with the findings that skelemin is unable to 
activate the receptors. We have built a tertiary model of αIIbβ3 integrin cytoplasmic tails 
complexed with the tandem domains. While some of the interactions between K716 side 
chain of β3 tail and skelemin may occur in the presence of αIIb subunit still bound to β3, 
disruption of membrane-proximal α/β clasp and release of αIIb F992 and β3 H722/D723/E726 
side chains is necessary for αIIb to bind to skelemin and for β3 to stabilize its interface with 
skelemin. Thus, our model favors skelemin role as a stabilizer of the activated integrins 
and integrin clusters by connecting α and β subunits from adjacent receptors. 
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